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Objectif  du projet  
La SUMOylation est une modification post-traductionnelle des protéines. La 
détection par chromatographie liquide couplée à de la spectrométrie de masse 
est rendue difficile par leur faible abondance et par la faible présence de substrat. 
Méthodes | Expériences | Résultats  
L’utilisation de High-Field Assymetric Waveform Ion Mobility (FAIMS) résulte en 
une diminution significative du bruit de fond en LC-MS. Grâce au fractionnement 
effectué, il est possible d’identifier des peptides de faible abondance par LC-
MS/MS. La performance de FAIMS a été testée en comparant des analyses de 
digestats trypsiques de lysat de cellules HEK293 avec et sans FAIMS par LC-
MS/MS. 8260 peptides ont été identifiés (1165 protéines) avec FAIMS et 
seulement 4820 peptides (734 protéines) sans FAIMS. Quand un nombre 
représentatif de peptides synthétiques SUMO ont été ajoutés dans un digestat de 
HEK293, les analyses nano-LC MS ont montré une limite de détection 18 fois 
plus faible lorsque FAIMS y est couplé. Finalement, la sumoylation est une des 
premières réponses cellulaires au stress thermique. Donc pour augmenter la 
concentration de protéines sumoylées, nous avons effectué un choc thermique 
(43°C) sur des cellules HEK293 exprimant SUMO3 mutante. Un enrichissement 
de SUMOIylation dans la fraction nucléaire a été observé après 60 min par 
immunobuvardage. Une analyse LC-FAIMS-MS/MS a donné une augmentation 
de 2 fois du nombre de peptides SUMOylés identifiés après choc thermique. 
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Figure 2: La différence de mobilité 
ionique des ions entre un faible et 
un haut champ électrique permet 
leur séparation avec FAIMS. 
 
Figure 3: Réponse au choc 
thermique à 43°C par 
immunobuvardage contre les 
anticorps SUMO 2/3.  
Figure 1: Vue d`ensemble de la 
proteomique. Après digestion, les 
peptides sont analyses par LC-
MS/MS ou ils sont fragmentes 
pour en déduire leur séquence. 
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Our greatest weakness lies in giving up. The most certain 
way to succeed is always to try just one more time. 
[Thomas A. Edison] 
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SUMMARY 
SUMOylation is a post-translational modification of proteins that is involved in different 
cellular processes including mitosis, DNA replication and transcription. However its detection by 
liquid chromatography coupled to mass spectrometry (LC-MS) can be challenging due to its low 
abundance and dynamic regulation. High Field Asymmetric Waveform Ion Mobility Spectrometry 
(FAIMS) helps in eliminating background ions which allows to improve the limit of detection. 
FAIMS separation is based on the differential mobility of ions between low to high electric field. 
In a preliminary experiment performed on a tryptic digest of HEK293 proteins, we identified 8260 
peptides (1165 proteins) with FAIMS compared to 4820 peptides (734 proteins) without FAIMS. 
The limit of detection was 12 fmol with FAIMS for synthetic SUMO peptides spiked in a complex 
tryptic digest and 183 fmol without FAIMS. A LC-MS analysis with FAIMS of a mutant SUMO3 
HEK293 cell line resulted in a 3-fold increase in the identification of SUMO peptides. 
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ABBREVIATIONS 
BSA Bovine serum albumin 
CID Collision-induced dissociation 
CV Compensation Voltage 
DC Direct current 
DTT Dithiothreitol 
ECL Enhanced chemiluminescence 
EDT Electron-transfer dissociation 
ESI Electrospray ionization 
FAIMS High-Field asymmetric waveform Ion mobility spectrometry 
FDR False discovery rate 
HCD Higher-energy C-trap dissociation 
HEK293 Human embryonic kidney 293 
HRP Horseradish peroxidase 
IE Inner electrode 
LC  Liquid chromatography 
LTQ Linear trap quadrupole 
MALDI Matrix-assisted laser desorption/ionization 
MGF Mascot generic format 
MS  Mass spectrometry 
MS/MS Tandem mass spectrometry 
Ni NTA Nickel nitrilotriacetic acid 
OE Outer electrode 
PBS Phosphate buffered saline 
PTM Post-translational modification 
RF Radio frequency 
rpm Revolutions per minute 
SDS PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SENP Sentrin/small ubiquitin-like modifier-specific protease 
SIM SUMO-interacting motif  
SPE Solid phase extraction 
SUMO Small ubiquitin-like modifier 
TBS Tris buffered saline 
TCEP Tris(2-carboxyethyl)phosphine 
TIC Total ion chromatogram 
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1. Introduction 
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1.1. THE OBJECTIVE OF THE WORK 
The aim of this project is to identify small ubiquitin-like modifier (SUMO)-modifed 
substrates and their modification sites using ion mobility and mass spectrometry. SUMOylation 
is a dynamic process, found in all common species, and is essential for eukaryotic life. Till this 
day, the exact outcomes and dynamics of this modification are not completely understood. For a 
better understanding of this post-translational modification (PTM), we aimed to identify SUMO 
target sites using mass spectrometry. However, there are several aspects that make this 
investigation difficult. First, this modification is highly dynamic and reversible. Secondly, cell 
extracts are highly complex and SUMOylated proteins are found at low concentrations with 
variable stoichiometry of modification site (1). Third, the sequences of SUMOylated peptides are 
branched, which makes the MS/MS spectra complex and hard to interpret. To improve 
sensitivity, nano LC-ESI-FAIMS-MS can be used. High-Field Asymmetric Waveform Ion Mobility 
Spectrometry (FAIMS) reduces background noise and allows for selective measurement of 
peptide groups in function of their charge state (2). This work comprises the following three 
aims: 
1. Determine the distribution of charge state as of function of the compensation 
voltage (CV, parameter FAIMS) for synthetic SUMO peptides and tryptic peptides 
from Human embryonic kidney 293 (HEK293) total cell lysate. 
2. Determine the limit of detection of synthetic SUMO peptides with and without 
FAIMS. 
3. Determine the dynamic change in SUMOylation during heat shock treatment for 
protein extracts isolated from a mutant HEK293 SUMO3 cell line. 
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1.2. SUMOYLATION 
SUMOylation regulated the activity, stability and the interaction of hundreds of proteins 
in different pathways. There are several cellular functions where the SUMO proteins are 
important. Some of these functions include: gene transcription, cell cycle and DNA repair (3). 
We can find SUMOylated proteins most frequently in the nucleus, where the SUMO enzymes 
are enriched (1). Additionally, free and conjugated SUMO is also present in the cytoplasm. All 
eukaryotes express at least one SUMO precursor protein. In humans we have 4 different SUMO 
isoforms, but only SUMO 1, SUMO 2 and SUMO 3 are ubiquitously expressed. SUMO 2 and 
SUMO 3 share 97% sequence identity and only differ by three amino acid residues. Antibodies 
cannot distinguish between these two isoforms. This work primarily focused on SUMO 3. An 
important feature of SUMO 1, 2 and 3 is that they all have the same glycine-glycine motif at the 
C-terminus. 
 
Figure 1: The different sequences of the human protein SUMO 1, SUMO 2 and SUMO 3. SUMO 1 contains 101 
amino acids; terminal cleavage with trypsin gives a peptide with 23 amino acids (ELGMEEEDVIEVYQEQTGGHSTV). 
SUMO 2 and SUMO 3 are distinguishable by their 3 different amino acids at the beginning of the peptide sequence; 
here marked in yellow. SUMO 2 and SUMO 3 consist of 95 and 103 amino acids, respectively. The last trypsin cleavage 
gives the peptides FDGQPINETDTPAQLEMEDEDTIDVFQQQTGGVY for SUMO 2 (34 amino acids long) and 
FDGQPINETDTPAQLEMEDEDTIDVFQQQTGGVPESSLAGHSF for SUMO 3 (43 amino acids). The di-glycine motif can be 
seen close to the end of the sequence in all three SUMO proteins. 
 
 
1.2.1. ENZYMATIC CASCADE 
SUMOylation of proteins is a reversible process. First, SENP proteases (sentrin/small 
ubiquitin-like modifier-specific protease) deconjugate SUMO modifications from target proteins 
and cleave terminal C-teminus residues of free SUMO to expose its di-glycine motif. This 
cleavage is required for the activation of SUMO and for the conjugation of SUMO to lysine 
residues of the target protein. Free SUMO are first transferred to the E1 activating enzyme 
(SAE1/SAE2) via a thioester bond. It is then transferred to the enzyme E2 (UBC9) to form an 
isopeptide bond. Finally, E3 ligases can bind specific substrate to catalyze a nucleophile attack of 
the target lysine once interacting to UBC9. As previously mentioned, SENP proteases can 
activate the SUMO protein as well as catalyze the deSUMOylation of proteins (1). If they activate 
the SUMO precursor protein, they are called endopeptidase because they break the peptide 
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bond. If they remove the SUMO modification from the target, the SENP is referred to as an 
isopeptidase. 
 
Figure 2 There are several enzymes involved in SUMOylation. First the SENP activates the SUMO precursor 
protein, then it is bound by the activating enzyme E1 and E2 and then conjugated to the target protein by a isopeptide 
link with the help of E3. The SUMO conjugation is a reversible process and the modification can be removed by a SENP 
protease.  
 
1.2.2. SUMO MOTIF 
SUMO attaches covalently to target proteins via an isopeptide bond. This process takes 
place between the C-terminal glycine of the mature SUMO sequence and the ε-amino group of 
the lysine residue from target proteins. Although there are different kinds of target motifs, the 
most common consensus motif is ψKXE/D. Where ψ is a large hydrophobic amino acid, K is the 
lysine which forms the isopeptide link with the SUMO, X is any amino acid, and the last residue 
is either an aspartate or glutamate residue. This is a reversible process where isopeptidase SENP 
can cleave the isopeptide bond. Moreover, SUMO can also bind non-covalently via a SUMO-
interacting motif (SIM) (4). 
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Figure 3: Isopeptide bond between the target and the SUMO peptide 
 
1.2.1. SUMOYLATION IN RESPONSE TO STRESS 
Protein SUMOylation is regulated by different environmental changes including viral 
infection, proteasome inhibition, and heat shock (5) (6). An accumulation of SUMO 2/3 
conjugates are detected under heat shock as well as treatments with ethanol, salt or oxidation. 
Similar results are observed when cells are treated with the protease inhibitor MG132.  
 
 
Figure 4: The overexpression of SUMOylation can be caused by stress or DNA damage. 
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1.3. MASS SPECTROMETRY 
1.3.1. IDENTIFICATION OF SUMO TARGETS BY MASS SPECTROMETRY 
SUMO target recognition is very difficult. The consensus motif ψKXE/D is very short and 
might be found frequently in mass spectrometry analysis. The occurrence of this motif does not 
necessarily imply that the corresponding lysine residue will be necessarily SUMOylated (7). To 
get a better understanding of the proteome, we can apply mass spectrometry based proteomics 
(8). With help of mass spectrometry we can identify modifications at a protein level.  
1.3.2. PROTEOMICS 
Proteomics allows us to have a better look at the different process that take place in cells. 
For instance, we can quantify proteins that are up or down regulated in diseases. In fact, 
proteomics is split in two phases: discovery and the targeted proteomics. In the discovery phase, 
we perform a global large-scale identification of peptides to determine which one are regulated. 
In targeted proteomics we are looking for specific peptides or modifications in proteins. To get 
the most comprehensive structural characterization of modified proteins, the Bottom-up 
method is used. The proteins are most often digested with the serine protease trypsin. Trypsin is 
mostly used because it cleaves specifically at the C terminus of lysine(K) and arginine(R), which 
both have basic residues found at the carboxyl terminus (9) (10). Another advantage is the 
relative high frequency of lysine and arginine in protein sequences. Also, the presence of lysine 
or arginine residues can be identified in tandem mass spectra by characteristic fragment ions at 
m/z 147.11 and 175.11. 
Protein quantification using mass spectrometry provides a deeper insight into the 
dynamics of organisms. The following figure is a brief explanation of the workflow in 
proteomics: proteins are digested to peptides, then the corresponding samples are separated by 
liquid chromatography prior to their analysis on the mass spectrometer. Bioinformatics tools 
then allow us to sequence and identify peptides for the acquired tandem mass spectra.  
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Figure 5: Basic overview of proteomics. After tryptic digestion, we get peptides that are analyzed in a LC-MS 
system. With the help of the mass spectrometer we produce tandem mass spectra. These are fingerprints of each 
peptide. We can identify peptides with the help of bioinformatics tools. Then we try to reconstruct the peptides 
sequences and assign them to their respectful proteins. 
 
1.3.2.1. NANO LC-MS 
In proteomics nanoscale liquid chromatography coupled to tandem mass spectrometry is 
used and it has a very high sensitivity and specificity. After separation on the liquid based 
system, the sample is transferred into the mass spectrometer via an electrospray source. 
Electrospray ionisation (ESI) and matrix-assisted laser desorption/ionization (MALDI) are 
common methods used to ionized and volatize the peptides in complex samples (8). Usually 
peptide amounts present in digest at present at sub M concentrations, and, low flow rates and 
small column diameters are typically to increase sensitivity. This improves at the same time the 
ionization efficiency of electrospray by forming smaller droplets (11). The spray is generated in 
an electric field between the end of the chromatogram system and the entrance of the mass 
analyzer and gives rise to the formation of a Taylor cone. LC effluent emerging from the emitter 
is subjected to the applied electric field and is nebulized into small droplets that undergo 
subsequent fission events and solvent evaporation to form droplets of smaller sizes. Ions 
contained within these smaller droplets undergo increasing electrostatic repulsion and are 
eventually expelled and analyzed by the mass spectrometer. 
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For this work we employed the Orbitrap Elite from Thermo. The instrument is composed 
of a combination of a linear ion trap and orbitrap which provide great advantages: robustness 
and sensitivity by the ion trap and high resolution and accuracy by the orbitrap (8). 
 
Figure 6: Ions enter the mass analyzer in the form of ion gas. In the first step they are trapped in the linear ion 
trap before they transferred to the orbitrap (12) 
 
The gaseous peptides enter the mass analyzer and the ion beam is focused through a set 
of stainless steel apertures to which an RF voltage is applied called the S-Lens. This S-lens has 
improved transmission of ions by a factor of 5 to 10 compare to previous design which did not 
have the S-lens. In MS mode, ions are travelling through the dual pressure LTQ ion trap and are 
stored in the C-trap to prepare them for the injection in the Orbitrap. The orbitrap mass 
analyzer is composed of a spindle-like central electrode and a barrel-like outer electrode. A DC 
voltage is applied between the two axially symmetric electrodes, resulting in a quadro-
logarithmic field. Ions are accelerated from the C-trap through an optical deflection system and 
are trapped radially around a central spindle electrode. The motion of the ions in the orbitrap 
involves axial oscillations along and rotation around the central electrode. The rotation 
frequency of the ions is dependent on the charge to mass ratio as described in Eq.1. This 
frequency is determined with the image current given by the ion movement around the central 
electrode. In MS/MS mode, two options are available. For both, precursor selection and 
isolation is performed in the LTQ ion trap. Then, the precursor can be either fragmented and 
analyzed in the LTQ ion trap (collision induced dissociation CID) or fragmented in the HCD 
collision cell. In this latter case, the ions are sent back to the C-trap and finally to the Orbitrap to 
be analyzed (higher-energy collisional dissociation HCD). CID is very fast but provides low mass 
accuracy on the fragments (± 0.5 ppm). HCD is slower than CID but provide a much better 
accuracy on the fragments (± 3 ppm).  
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Figure 7: Ions rotate around an axis with 
different frequency (12) 
𝜔 =  √
𝑧
𝑚
 ∙ 𝑘 
Equation 1: Frequency of the ions in the orbitrap 
 
 
1.3.2.1. SUMO MUTANT 
To facilitate the identification of SUMO proteins by mass spectrometry, a HEK293 cell line 
with a SUMO 3 mutant was used (13). The mutant SUMO 3 resembles the wild-type except for a 
few modifications. There is a His6 tag on the N terminus which allows for selective enrichment 
on a Ni-NTA column. There is also a strategic replacement of glutamine 87 with a lysine. 
Digestion by trypsin provides us with a 5 amino acid long peptide on the target lysine instead of 
32 amino acids. A Q88N substitution was also introduced to distinguish SUMO 2 and SUMO 3 
modifications by mass spectrometry. 
 
 
Figure 8: Created SUMO 3 mutant in human cell HEK293 (13). On the N terminus there are six consecutive 
histidine residues and there is a lysine at position 87 instead of a glutamine. 
 
Unfortunately bioinformatic applications are designed to analyze linear peptides and the 
interpretation of MS/MS spectra is compromised by the occurrence of branched peptides. 
Conventional search against a database with Mascot leads to low score identifications. The 
following are examples of MS/MS spectrums of a linear and a branched peptide.  
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.  
Figure 9: MS/MS spectre for linear peptide AKPVDR (3) 
 
Figure 10: Same peptide but this time SUMOylated (branched peptide). We get a complex MS/MS spectre and 
bioinformatic tools interpret them as false (3) 
 
Previous experiments by Thibault’s lab members also showed that the score in HCD mode 
for SUMO is better than CID or ETD (3). This was achieved using a representative number of 
synthetic SUMOylated peptides (7-21 amino acids long) to test the three different 
fragmentation methods and tabulating the occurrence of specific SUMO fragments. They 
showed that there was a higher frequency with HCD than with the CID or ETD (3). Moreover, 
they created a novel bioinformatic tool called MS/MS edition to increase the identification score 
by Mascot for SUMO modified peptides.  
1.3.2.2. REMOVE SUMO TAGS BY MS/MS EDITION 
 
Low m/z                                High m/z 
 
 
Figure 11: Specific SUMO 3 fragments from the HEK293 SUMO 3 mutant (3) 
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The following explanation refers to the SUMO 3 mutant tryptic peptide that comprise the 
pentapeptide NQTGG linked to the modified lysine residue via an isopeptide bond. In a typical 
case we see the fragments of the reporter ions at a low m/z value and the neutral losses at high 
m/z value. These fragments are characteristic of the branched part of the peptide and disturb 
the software. With an in house software MS/MS edition we can edit the MS/MS spectra and 
convert it into a ”linearized” version more easily interpreted by conventional search engines.  
 
Figure 12: Specific SUMO 3 
fragments. At low m/z value we expect 
to see the fragments of the reporter 
ions like the loss of N, NQ, NQT … At 
high m/z we see the neutral losses. 
 
Figure 13: The typical 
fragments were removed to simplify 
the MS/MS spectre 
 
Figure 14: The removed mass 
will be added to the peak to get the 
right mass 
 
After linearization of the MS/MS spectre as described above, using the common 
sequencing and data base softwares is less confusing and the identification scores is much 
higher. With help of the SUMO 3 mutant and the mgf editing using MS/MS edition we are able 
to use proteomic mass spectrometry to successfully identification SUMOion sites in the 
proteome. 
1.3.1. FAIMS 
FAIMS adds an additional dimension of separation and can be applied as a novel approach 
for the identification of SUMOylated target sites. In proteomics the samples are complex and a 
one-dimension separation is usually not enough due to matrix complexity (14). We thus have to 
find a way to improve selectivity. In addition, high background noise and low abundance of 
some peptides makes it difficult to detect them. Characterization of the entire complement of 
proteins is never feasible with a normal separation system since instrument performances are 
limited. With FAIMS we can reduce background noise and select for transmitted ions based on 
their different mobility in high and low electric field (15). If we scan under various conditions, we 
can detect different kinds of ions and the fractionating step in the gas phase allows for the 
separation of singly charged peptides from multi charged peptides.  
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Figure 15: Overview of the basic differences between LC-MS and LC-FAIMS-MS. With LC-MS ions pass directly 
after ionization in the mass spectrometer. With FAIMS we transmit only ions with the desired mobility to the mass 
analyzer (16) 
 
 
1.3.1.1. SEPARATION  
The separation in FAIMS takes place between 2 electrodes, which produce an electric 
field, and an inert carrier gas that helps to mobilise the ions forward to the mass analyzer. The 
electric field is applied via an asymmetric waveform (V(t)) and during one cycle this waveform 
integral voltage-time product is equal to zero (Vhighthigh + Vlowtlow = 0). The maximal amplitude for 
the applied cycle voltage is called the dispersion voltage.  
The ions have different drift velocity and so not all of them need the same requirements 
to migrate to the electrodes. The traveled distance to the electrode can be calculated with 
equation 2. Where K is the ion mobility which is independent on the low electric field, this 
means the velocity in the low electric field is proportional to the field strength. This is not the 
case in high electric field. In high electric field the behavior of ions depends on the electric field 
thus we speak about Kh. If K and Kh are identical, the traveled distance is the same and the ion is 
back to its initial position after one waveform cycle. If Kh > K the ions displace themselves in 
direction to the mass spectrum.  
 
𝑑 = 𝑣 ∙ 𝑡 = 𝐾 ∙  𝐸 ∙  𝑡 
Equation 2: traveled distance of ions in an electric field 
 
 
In addition to the dispersion voltage, a compensation voltage (CV) is applied on the lower 
electrode to prevent ions from drifting towards the electrode. In the case where ions touch the 
electrode they become neutral and do not pass through the electrodes to the mass analyzer. 
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The compensation voltage value is specific for each compound and allows us to regulate the 
separation mechanisms. In short, the separation is achieved because of the various types of ions 
travelling to different distances (17). 
 
Figure 16: Scheme depicting ion separation in FAIMS. The behaviour of different ions in the electric field vary 
and allows for separation. 
 
1.3.1.2. FAIMS FOR TARGET IDENTIFICATION OF SUMOYLATED SITES 
Digestion by trypsin has different advantages. One of them is the positive charge of 
lysine/arginine after tryptic digestion. With the SUMO modification we have also a positive 
charge arising from the N-terminus amino group of the SUMO chain. The possibility of getting a 
multiply charged peptide is high and we can make use of this in ion mobility spectroscopy. 
FAIMS also provides the possibility to increase the signal to noise ratios by adding a new 
dimension without increasing the analysis time. Given that less than 1% of the peptides are 
SUMOylated eliminating background noise is a necessity. The following is an example of an MS 
spectrum without and with FAIMS to show the decrease in background noise. 
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Figure 17: The full MS spectrum for the SUMO 3 modified peptide NLLHDNELSDLKEDKPR (4+) m/z 624.31 at 
400 fmol. Above is a spectrum with the normal nano-LC-MS system, below is with nano-LC-FAIMS-MS. The signal to 
noise ratio is increased 5-fold when using FAIMS.  
 
  
noFAIMS 
 
    FAIMS 
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2. Materials and Methods 
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2.1. MATERIAL 
In the following tables all of the laboratory equipment and materials that were used. 
2.1.1. EQUIPMENT 
Table 1: Labor equipment which was used for the different manipulations in the laboratory 
Speed Vac Thermo SPD131DDA-115 
Incubator Eppendorf Thermomixer R 
Centrifuge Sorvall Legend RT 20057916 
UV CO2 Incubator Panasonic UV Safe cell MCO-19AIC-PA 
Steril Gard III Advannced Hood Baker Company SG-403A 
Power Pac Universal Bio Rad 164-5070 
Xray cassette Fisher FBXC810 
Digital Dry Bath Labnet D1200  
Multiscan spectrum plate reader Thermo electron corp. 
 
2.1.2. CHEMICALS  
Table 2: Chemical list for the different manipulations in the laboratory 
Formic acid (98%) EMD FX0440-7 
Acetonitrile HPLC grade Fisher Scientific A998-4 
Trypsin modified (sequencing grade) PROMEGA V511A 
tris(2-carboxyethyl) phosphine (TCEP) Themro Scientific 77720 
Ammonnium Bicarbonate (98-101%) Bio Basic VWR CA99501-001 
2-Chloroacetamide SIGMA C0267 
Methanol VWR CA-MX0475 
Glycine VWR CA-EM4840 
Tris base VWR CA-EM9230 
Imidazole (99.0%) WVR CA99501-844 
Sodiumphosphate monobasic 
monohydrate 
Sigma S9638 
Guanidine Hydrochloride Bio Shop GUA003.1 
SDS  Sigma L3771 
 
2.1.3. PROTEINS AND PEPTIDES 
Table 3: List of proteins and peptides used for different manipulations 
 Supplier Use 
Alcohol Dehydrogenase from 
Saccharomyces cerevisiae 
Sigma A7011, 
LOT# 041M7354V 
Promix solution 
Bovine Serum Albumin BioShop ALB00150, 
LOT# 3927998 
Promix solution 
Carbonic Anhydrase from bovine 
erythrocytes 
Sigma C3934, 
LOT# 081M1626V 
Promix solution 
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Cytochrome c from Saccharomyces 
cerevisiae 
Sigma C2436, 
LOT# 037K7008V 
Promix solution 
Enolase from Saccharomyces 
cerevisiae 
Sigma E6126, 
LOT| 097K7690V 
Promix solution 
Hemoglobin human Sigma H7379,  
LOT# SLBC0633V 
Promix solution 
Phosphorylase b from rabbit muscle Sigma P6635, 
LOT# 110M7675V 
Promix solution 
Transferrin human Sigma T3309, 
LOT| 0L194488 
Promix solution 
Angiotensin human acetate salt 
hydrate 
Sigma A9650 
 
FAIMS spray position 
SUMO synthetic (see annex 6.4) JPT Peptide Technologie 
GmbH  
16034 
PO#U629407_2004655 
Linearity 
SUMO 1 ‘GGTQE’ N-terminus amine 
51 peptides  
C terminus lysine acid 
45 peptides 
C terminus arginine acid 
SUMO 3 ‘GGTQN’ N-terminus amine 
40 peptides  
C terminus lysine acid 
56 peptides 
C terminus arginine acid 
 
2.1.4. CELL CULTURE AND WESTERN BLOT 
Table 4: Substance and equipment used for the cell culture of HEK293 cell line 
 Supplier Use 
Dulbecco’s modified eagle medium 
(DMEM) 
Thermo Scientific 
SH30081.02 
cell culture 
Fetal bovin serum (FBS) deactivated 
filtred  
SERADIGM 1400-500 cell culture 
Phosphate buffered saline (PBS) HyClone SH30258.01 cell culture 
Genectin Gibco 10131-027 cell culture 
Antibody SUMO 2 Invitro LOT 394064A Western Blotting 
Antibody α-Tubulin Cell Signaling # 2144S LOT 
4 
Western Blotting 
Antibody Histone H3 Cell Signaling # 9715S LOT 
20 
Western Blotting 
Anti Rabbit IgG (H+L) HRP Merck AP307P Western Blotting 
Blotting paper VWR 28298-020 Western Blotting 
Tween 20 Sigma P1379 P1379 Western Blotting 
Nitrocellulose membrane Pall DR-058711112E Western Blotting 
Full blue Xray films Cie univ de rayons X du 
Canada, 1081728 
Western Blotting 
96 well plate VWR CA62406-343 Bradford  
Ni-NTA Agarose QIAGEN 1018240 Purification  
NuPAGE (Mes SDS Running Buffer) Novex NP0002 Gel electrophoresis 
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Criterion XT Precast Gel (4-12% Bis-
Tris) 
Bio Rad 345-0124 Gel electrophoresis 
Protein Assay Dye Reagent 
Concentrate  
Bio Rad 500-0006 Bradford 
Amersham ECL Western Blotting 
Detection Reagents 
GE Healthcare RPN2235 
and RPN2106 
Detection Western 
Blot 
BLUeye Prestained Protein Ladder  FroggBio PM007-0500  
(10-245 kDa) 
Gel electrophoresis 
 
2.2. METHODS 
2.2.1. CELL CULTURE 
2.2.1.1. CELL CULTURE 
For culture of HEK293 WT and HEK293 SUMO3 cells, Dulbecco’s Modified Eagles Medium 
(high glucose) supplemented with 10% fetal bovine serum, 1% Penicillin/Streptomycin Solution 
and 1% L-Glutamine was used. The cells were grown at 37 °C in a 5% CO2 incubator. 750µg/ml 
Geneticin was added to maintain the selection of HEK293 SUMO3 cells.  
2.2.1.2. HEAT SHOCK 
To study the effect of stress on protein SUMOylation, the cells were treated with a heat 
shock at 43°C. We added preheated medium (43°C) to the cells and incubated them at 43°C in a 
5% CO2 incubator for different periods of time. For the large scale study, the cells were treated 
with a 60 minute heat shock. 
2.2.1.3. CELL COLLECTION 
The medium is removed and the cells washed with PBS. The cells are subsequently 
collected in fresh PBS. The cells are then centrifuged for 10 minutes at 1000 rpm. The PBS 
(supernatant) is removed to isolate the cell pellet. The pellet is washed again with PBS and 
centrifuged for 10 minutes at 1000 rpm. The PBS is removed and the cell pellet is stored at -20°C 
for least for 12 h. 
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2.2.2. PROTEIN EXTRACTION AND PURIFICATION 
Figure 18 shows the workflow for the treatment of the mutant HEK293 SUMO3 cell line. 
After inducing stress by heat shock, a nucleus – cytoplasm fractionation is done. Afterwards the 
purification on Ni NTA beads of the 6 x His-tagged proteins is done. For the mass spectrometry 
analysis the proteins are digested by trypsin. 
 
Figure 18: Brief overview of the workflow for the heat shock treatment (3). In the first step, the nucleus and 
cytoplasm are separated. After NiNTA purifications we digest with trypsin and measure on the LC-MS. 
 
LSB 
10 mM Tris pH 7.6 
stock solution 
1.5 mM magnesium chloride 
20 mM 2-Chloroacetamide  
add fresh 100 X Protease Inhibitor 
100 X Phosphatase Inhibitor  
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BUFFER A 
8 M Urea 
stock solution 
100 mM Sodiumphosphate monobasic monohydrate 
10 mM Imidazole 
10 mM Tris-HCl pH 8 
20 mM 2-Chloroacetamide  
add fresh 
10 mM β-Mercaptoethanol 
 
BUFFER B 
8 M Urea 
stock solution 
100 mM Sodiumphosphate monobasic monohydrate 
20 mM Imidazole 
10 mM Tris-HCl pH 6.3 
10 mM β-Mercaptoethanol add fresh 
 
 
2.2.2.1. FRACTIONATION OF NUCLEAR/CYTOPLASMIC FRACTIONS 
The cell pellet is dissolved carefully in LSB buffer, and if necessary, it is vortexed slightly. 
Incubate with the phosphatase and protease (for SENP) inhibitor for at least 30 minutes with 
shaking (4°C). After, centrifuge for 15 minutes at 215g. The supernatant is the cytoplasmic 
fraction. Wash the nucleus pellet with LSB buffer and centrifuge again at 215g for 15 minutes. 
Remove the wash LSB solution and add buffer A to the nuclear pellet. Till this point, all 
manipulations were performed on ice.  
2.2.2.2. NUCLEUS LYSIS 
After adding 8M Urea (buffer A), the proteins are denatured. Vortex vigorously the pellet 
solution and sonicate 2 times for 10 seconds to shear the DNA. Centrifuge 15 minutes at 16000 g 
and transfer the supernatant to a fresh tube and label as nuclear fraction. 
2.2.2.1. PROTEIN ASSAY 
A Bradfords assay is used to quantitate the protein content of the various fractionated 
samples. The calibration curve includes standard solutions with concentrations of 0, 5, 25, 50, 
125, 250, 500, 750, 1000 µg/mL of bovine serum albumin. For measurements, we take 96 well 
microplates and scan the absorbance at 595 nm. According to the Lambert Beer's law. 
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𝐴 =  𝜀 ∙  𝑙 ∙  𝑐 =  𝜀 ∙  𝑙 ∙  
𝑛
𝑉
 =  𝜀 ∙  𝑙  ∙  
𝑛
𝑠 ∙ 𝑙 
 =  𝜀 ∙  
𝑛
𝑠
  
Equation 3: Lambert Beer law. Sample volume is negligible. 
 
where 
 
A =  absorbance [ - ] 
ε =  molar extinction coefficient [ M−1 cm−1 ] 
l =  pathlength; height well [ cm ] 
c =  molar concentration [ M−1 ] 
n =  amount of substance [ mmol ] 
V =  volume well [ cm3 ] 
s =  surface well [ cm2 ] 
 
Consequently, the volume of the sample has no influence when the incident beam is 
perpendicular to the plane of the 96-well plate. By default, 190 µl Bradford reagent and 5-10 µl 
sample solution is taken for the direct preparation in each well of the micro plate.  
2.2.2.2. NI-NTA PURIFICATION 
For the Ni-NTA purification we add 1 mL of Ni-NTA beads to 50 mg of proteins. In practical 
terms, that means we have to take 2 mL of Ni-NTA Agarose beads since the Ni-NTA solution 
comes as 50% beads and 50% ethanol mixture. The final calculated volume of Ni-NTA beads is 
centrifuged for 1 min at 215 g. The supernatant is removed. Wash the beads 4 times with buffer 
A. The sample is added to the equilibrated beads and incubated overnight at room temperature. 
Centrifuge for 1 min at 215 g and remove the flowthrough (keep it for western blot analysis). 
Wash beads 1 time with buffer A, 4 times with buffer B and 2 times with 50 mM ammonium 
bicarbonate. To remove the proteins from the beads for Western Blot, use 200 mM of Imidazole 
buffer (with 20 mM Tris adjust at pH 7.0) and incubate for 10-20 min at room temperature. 
2.2.3. WESTERN BLOTTING 
 
Figure 19: Western blot Workflow. We first run a SDS PAGE, transfer the proteins on a nitrocellulose 
membrane and incubate the membrane with primary and secondary antibodies. ECL is added to the membrane and 
the emission is captured on Xray films.  
Gel 
electrophoresis 
Protein Transfer Antibody's ECL Imaging 
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TBS 0.1% TWEEN (TBST) 
2.42 g Tris-HCl  
8 g NaCl  
1 ml Tween 20  
1000 ml Water  
 adjust pH to 8 with HCl  
 
TRANSFER BUFFER SOLUTION  
2.9 g Tris-HCl  
14.5 g Glycine  
200 ml Methanol  
800 ml Water  
 
LAEMMLI BUFFER 3X: 
2.4 ml 1M Tris-HCl pH6.8 
 
3 ml 20% SDS 
3 ml Glycerol 100% 
1.6 ml β-mercapthoethanol 
6 mg Bromophenol blue  
 Add to 10 ml with water  
 
2.2.3.1. SDS PAGE  
Take 10 µg of protein for each sample and reconstitute in 1X Laemmli buffer. Heat the 
samples for 10 minutes at 95°C on a heat block. Before loading the gel, vortex the sample. Load 
the samples into each well and deposit 5 µl for the protein molecular weight marker. Run the gel 
in the appropriate apparatus for approximately 50 minutes at 150V or until the tracking dye 
reaches 1 cm from the bottom of the gel. 
REMARK: As previously mentioned, if you load Ni NTA samples, use 200mM Imidazole 
buffer (20mM Tris, adjust at pH 7.0) instead of Laemmli buffer. This is to elute the proteins from 
the beads.  
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2.2.3.2. PROTEIN TRANSFER 
 
Figure 20: Schema of the order to prepare the wet transfer of the proteins from the gel to the membrane (18) 
  
Remove the gel from the electrophoresis unit. Cut the gel, membrane and blotting papers 
to the desired size and equilibrate all of them in the transfer buffer solution. Then, pack the 
transfer casette without any airbubbles in the order that is showed in figure 20 .Transfer 
proteins for 90 minutes at 600 mA. Incubate the membrane for 10-15 min in Ponceau S reagent 
to verify the integrity of the transfer. The Ponceau stain is removed from the membrane with 
several water washes.   
2.2.3.3. INCUBATION WITH ANTIBODY 
The membrane is blocked with a 5% milk in TBST prior to probing with the primary 
antibody. The membrane is then cut in different parts for the loading control. For the nucleus 
we cut bellow around 24 kDa and incubate it with the anti-Histone H3 antibody. We expect to 
detect a band of approximately 17 kDa. The recommended dilution of the antibody for western 
blotting is 1:2000 in 1% milk TBST (19). This antibody is an isotype of rabbit IgG. For the 
cytoplasm blot we cut above around 70 kDa is incubated with an antibody blotting against α-
tubulin, which is also an isotype of rabbit IgG. The band should be visible at 50 kDa and the 
recommended dilution ratio is 1:1000 (20). For the incubation with antibody against SUMO 2 we 
take the whole membrane for blotting. Like the other two antibodies, it is an isotype of rabbit 
IgG. Blots are incubated overnight at 4°C or for 2 hours at room temperature.  
(-) Black side 
 
 
Spong 
Blotting paper 
Gel 
Nitrocellulose membrane 
Blotting paper 
Spong 
 
 
(+) White side 
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In the next step, the primary antibody solutions are removed and the blots washed 2 
times quickly and two times for 20 min with TBST. The membrane can now be incubated under 
gentle agitation for 1 hour at room temperature with the secondary antibody. The secondary 
antibody is an anti-rabbit IgG, HRP-linked antibody. After incubation, the blots are washed as 
previously explained. The wash steps are important to keep the back ground noise as low as 
possible.  
2.2.3.4. DETECTION WITH ENHANCED CHEMILUMINESCENCE  
 
Figure 21: The principle of detection in Western blotting (18). Primary antibody binds to the target protein. 
Followed with a secondary antibody containing HRP (enzyme horseradish peroxidase). The enzyme linked antibody 
with HRP reacts with the ECL reagent and resulting emission detected. 
 
Moist the membrane with sufficient ECL developing solution. For the histone blot, use the 
normal sensitive reagent, and for α-tubulin and SUMO blots, use the highly sensitive solution or 
a mixture of both. Put the membrane in a vinyl protector which is taped into an X-ray cassette. 
Expose the film for different lengths of time to develop the film. 
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2.2.4. IN SOLUTION DIGESTION 
Dissolve the protein sample in 50 mM NH4HCO3 to a known concentration (the following 
amounts correlate for 1 mg of proteins.) Add 10 µl of TCEP to the sample to reduce the disulfide 
bonds. Incubate for 30 minutes at 37°C. Then, add 100 µl of 5 mg/ml chloroacetamide to 
alkylate the free sulfhydryl groups from the cysteine residues. Incubate for 30 minutes at 37°C. 
The unracted chloroacetamide is quenched with 10 uL of DTT at 500 mM. The digestion of the 
reduced and alkylated protein is done by adding 20 µg of trypsin (1:50 ratio to protein). Incubate 
for 4 h or overnight at 37°C.  
2.2.5. DESALTING 
Formic acid is added to a 1%final concentration. Condition the HLB extraction cartridge 2 
times with 50 v/v% methanol (0.1% FA) and 3 times with Millipore water. Load the sample, wash 
with Millipore water and elute with 50 v/v% methanol (0.1% FA). The sample is then lyophilized 
to dryness. 
2.3. MASS SPECTROMETRY ANALYSIS 
First, the samples were analyzed after trypsin digestion on the LTQ-Orbitrap Elite mass 
analyzer coupled to an Eksigent nanoLC sytem and a nano ESI source.  
2.3.1. SAMPLE PREPARATION 
In general, 1 µg of digested protein dissolved in 0.1% formic acid was injected per 
replicate/CV. 
2.3.2. LC SEPARATION SYSTEM 
Prior to separation on the analytical column, the sample is passed through a pre column 
with the same stationary phase as in the analytical column. The pre column serves to desalt the 
sample and to remove the coomassie staining. The prevalent length for the pre column is 50 mm 
and for the analytical column 15 cm.  
2.3.2.1. 1D LC 
The peptides are eluted from the pre and analytical columns with a gradient of 0-40% 
acetonitrile in 0.2% formic acid. The flow for the nano LC system rate is 600nL/min. The 
following tables describe the gradient for general separation.  
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Table 5: standard gradient for a 70 min run method 
Time 
[min] 
0.2% formic acid in water 
[%] 
0.2% formic acid in acetonitrile 
[%] 
0 95 5 
56 60 40 
57 40 60 
58 40 60 
59 95 5 
70 95 5 
 
Table 6: standard gradient for a 120 min run method 
Time 
[min] 
0.2% formic acid in water 
[%] 
0.2% formic acid in acetonitrile 
[%] 
0 95 5 
106 60 40 
107 40 60 
108 40 60 
109 95 5 
120 95 5 
 
2.3.2.2. 2D LC 
The separation of digested proteins can be performed with two-dimensional 
chromatography. Digested proteins were loaded first on a SCX trap column and then eluted by a 
sequential ammonium acetate elution (0 – 250 – 500 – 750 – 1000 and 2000 mM) at pH 3.5. The 
cleaning step of salts in a C18 pre column and analytical column separation remain the same as 
for the 1D LC systems. 
2.3.2.3. COLUMN 
LC nano columns are packed in house under Nitrogen (see annex 6.5) 
 Capillary:  ID 52 µm ex Polymicro Technologies (Part #106815017) 
    ID 150 µm ex Polymicro Technologies (Part #1068150024) 
REVERSED PHASE 
 Stationary Phase: Jupiter 3µ C18 300 Å ex phenomenex 04A-4263 
 Membrane :  SPE Disk EMPORE 2215-C18 (Octadecyl) 47mm ex 3M 
CATION EXCHANGE Cartridge 
 Stationary Phase: Opti guard 5µ SCX 300 Å ex  
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2.3.3. MASS ANALYZER 
Thermo ScientificTM Orbitrap Elite mass spectrometer. HCD activation mode with 
normalized collision energy 30% for SUMO peptides and 35% for common peptides in positive 
mode. 106 ions were accumulated in the Orbitrap before they were passed over to the linear ion 
trap. The resolutions for the MS is 60000 at 400 m/z and 15000 for the MS/MS. A minimal signal 
of 10000 is required.  
2.3.3.1. FAIMS 
Thermo Scientific™ high-field asymmetric waveform ion mobility spectrometry (FAIMS) 
has an interface with a 1.5 mm gap and a curved wall ion inlet between the electrodes. Spray 
position is diagonal and nitrogen is used as the gas. The temperature in the inner electrode is 
70°Cand 90°C for the outer electrode. A Vhigh –of 5000V and Vlow of +1000V were used as 
dispersion voltages. 
 
Figure 22: Diagonal ESI source for FAIMS 
 
 
 
Before injecting with the FAIMS ESI source, we had to find the optimal position of the 
spray. Usually, we fix the right position with help of the cameras. But unfortunately, this is not 
possible with this kind of source. To overcome this we infused a solution of angiotensin (0.2 
µg/µL in 50% MeOH in 0.2% formic acid) to manoeuvre them into the optimum diagonal 
position. We scanned through a CV range to determine the optimal CV range for Angiotensin 
(peptide observed at an m/z of 450.24 in a 2+ state). We found the optimum had a 
compensation voltage of about -50V. When this step is done, the position can be adapted. 
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2.3.3.2. SYSTEM TEST SOLUTION: PROMIX 
To test and control the LC-ESI-MS system, we use a solution, called Promix. The Promix is 
a complex tryptic digested solution, composed of 8 proteins from different species (see protocol 
6.6). The corresponding LC-MS analysis is used as a quality check test to ensure that operational 
system performance is achieved. This includes a defined value of the signal intensity, the control 
of specific precursor ions and their retention time as well as a comparison to the LC 
chromatograph of previous promix runs. 
 
 
Figure 23: Above example for a LC chromatogram of the Promix solution (July 2014) of 8 tryptic digested 
proteins. The sample was injected on the Thermo Scientific Orbitrap Elite mass spectrometer. Above are the 
chromatograms of each digested peptide. 
 
In proteomics, the amount of sample to analyse is usually low. To prevent losing sample 
due to instrument problems and to have optimal conditions during analysis, the promix is useful. 
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2.4. SOFTWARE 
RAW data’s were acquired with XCalibur. For database searches, clusterings and 
validations of the results, different software’s were used. The following table shows all of them. 
Table 7: List of different bioinformatic software’s 
In
st
ru
m
en
t 
co
n
tr
o
l 
Xcalibur 
 
Thermo (version 2.2, 
2011.08.11) 
instrument control and 
data analysis 
D
a
ta
 p
ro
ce
ss
in
g
 
ProteoProfile 
 
InHouse software IRIC 
(version 3.2014.05.23) 
Extract peptides from RAW 
file (peptide card , 
sds.file)Clustering, remove 
SUMO tag, recalibrate 
RAW files 
PEAKSTM7 Bioinformatics 
Solution Inc.(7) 
De novo sequencing – 
database search – PTM 
Identification 
 
 
 
 
 
 
MASCOT Daemon 
 
matrixscience Search algorithm for Mass 
Spectral proteomics 
peaklists 
 
Scaffold 
 
Proteome Software 
(4.3.4)  
Visualize and validate 
complex MS/MS  
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2.5. DATA PROCESSING 
We convert .Raw Data files from XCalibur Software to Mascot generic format (MGF) by 
Mascot Distiller. The database UniprotHuman (37275 sequences) is used with a mass tolerance 
of ± 15 ppm and MS/MS tolerance ± 0.02 Da. The reason for this relative high tolerance value is 
due to the fact that we have no set mass to control the calibration. With help of the inHouse 
software MS/MS editions (part of the ProteoProfile package) we can edit the mgf files and 
remove the SUMO tags from the MS/MS to aid in SUMO peptide identification. For the 
identification of the SUMOylated peptides we take the mgf.edited files gereated from MS/MS 
edition and run the Mascot search again against the UniprotHuman database. For variable 
modifications we look for GlyGly (K), deamidated (NQ) and SUMO 3 (K). The maximal number of 
missed cleavages by trypsin was set to 3. In some case a Peaks search with the .Raw files is 
launched in parallel to the Mascot search. The parameters are the same. To validate the results 
of the heat shock we set the FDR at 2.0% and we take only the spectra with at least 3 fragments 
(done manually). For SUMO synthetic peptides we are using a database with the 96 SUMO 1 as 
well the 96 SUMO 3 peptides. 
 
Figure 24: The general procedure to process the data for SUMO site identification. 
 
A search against a database compares the experimental spectra with theoretical spectra. 
It they are equivalent the peptide is assigned, if the experimental spectre is more or less the 
same, it is unassigned. If the sequence is the opposite, it is a DECOY peptide. The false discovery 
rate (FDR) is the ratio between the decoy peptides and the assigned peptides. 
2.5.1. CLUSTERING WITH PROTEOPROFILE 
To compare between different fractions, conditions or replicates, the software 
ProteoProfile allow us to create peptides cards (plot retention time to m/z plus charge state) 
and clustering. For the peptide cards, a threshold is set. Threshold is the value of the signal 
where we can detect peptides and not background. For FAIMS, measures on the Elite Orbitrap 
the Threshold is in general set at 1000, for noFAIMS it is set at 5000. The reason for the lower 
threshold with FAIMS is due to the significantly reduced background.   
aquiste RAW 
file (XCalibure) 
generate mgf 
file (Mascot) 
mgf edited 
(ProteoProfile) 
database 
search 
(Mascot) 
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2.6. COMPARISON FAIMS VS NOFAIMS  
Basically, complex samples are challenging for mass spectrometry. Background noise makes life 
complicated and the discovery of a whole proteome impossible. To demonstrate the 
performance of FAIMS, we injected a tryptic solution of the total cell lysate from HEK293. 
 
Figure 25: Workflow to demonstrate the performance of FAIMS compared to noFAIMS. The parameter of the 
mass analyzer were the same. For the validation of the data we used Peaks and for the data base search we used 
UniproHuman. After this we create the peptides cards as well the clustering with ProteoProfile. To get the overlap of 
the two conditions we used the Scaffold software. 
 
To identify HEK293 peptides, we injected our solution on the Orbitrap Elite and instead of 
replicates, we scanned a range of 12 different CV voltages (-28V to -78V in two steps CV) with 
FAIMS. The common nano LC-MS analysis (noFAIMS) was done with 12 replicates. With this 
method, we used a TOP5 approach (5 MS/MS) for each CV step (FAIMS) or a TOP12 approach 
for the replicate (noFAIMS). The amount of protein injected was 1 ug per injections. To compare 
the two methods, we analyzed at the detected, identified and quantified peptides. Clustering 
without a database search gave us the peptides that were detected (peptide cards). If we add 
the identification files in the cluster step, we get the list of identified peptides. For the frequency 
of quantified peptides we set the limit for the signal to noise ratio at 3. For the false discovery 
rate (FDR) we took only the unique peptide sequences that were lower than 1.0%. 
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2.7. LINEAR DYNAMIC RANGE OF DETECTION AND QUANTITATION FOR SUMO 1 AND SUMO 3 
PEPTIDES 
To determine the limit of detection 
(LOD) of SUMO peptides, a number of 
representative SUMO 1 and SUMO 3 
synthetic peptides (96 for each isotype) 
were used. With the synthetic SUMO 
peptides, we prepared a serial dilution to 
prepare solutions with final injection 
concentrations of 20 – 100 – 200 – 400 – 
1000 – 2000 fmol. The pure peptides 
were used for the first injections, and for 
the second injection set they were spiked in 1 µg of HEK293 cell lysate. The measurements were 
acquired with FAIMS and noFAIMS. Each condition were conducted in triplicates. For the FAIMS 
we stepped over the CV range -34V to -85V by acquiring 3 CV per MS (-40V-37V-34V | -49V-46V-
43V | -58V-55V-52V | -67V-64V-61V | -76V-73V-70V | -85V-82V-85V). 
 
 
After clustering for the linearity curves, we looked at each spectrum manually to 
determine the signal to noise ratio. The procedure was as follows: The average of the intensity 
(Full MS) for the triplicate was calculated for the lowest concentration point in which the SUMO 
peptide was detected. The signal of the noise was taken before the signal of the precursor ion of 
the peptide.   
Figure 26: Overview for the 4 different conditions to 
determine the LOD for SUMO 1 and SUMO 3 peptides with FAIMS 
and noFAIMS 
High  
Figure 27: Example of how the limit of detection was manually determined  
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3. Results and Discussion 
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3.1. OPTIMIZATION OF FAIMS INTERFACE 
With FAIMS we have different parameters to optimize. There are no general rules that we 
can follow to get the best conditions. To optimize the instrument parameters for SUMO 
peptides, we tested different parameters like the gas flow, temperature of the electrodes and 
the dispersions voltage. 
 
Figure 28: Shema for gas flow at the 
inlet of the outer and inner electrode 
The figure on the left shows a sheme of the 
FAIMS interface. A gas flow passes through the outer 
and inner electrode. The electrode are individually 
adjusted to heat the electrodes. The temperature has to 
be stable because of the influence by the gas intensity 
(21). The dispersion voltages is the peak maximum for 
one waveform cycle and it is applied on the two 
electrodes. The compensation voltages is applied on the 
inner electrode to prevent the ions from drifting onto 
the electrodes. 
 
3.1.1. GAS FLOW 
Angiotensin infusion was used to determine the optimal gas flow. Moreover, the stability 
of the signal can fluctuate as well. If we change only the flow parameter we observe a higher 
Intensity for Angiotensin at 1.5 L/min but the signal is not stable. If the flow is at 2.5 L/min the 
intensity is lower but the signal more stable over time. The best conditions we obtained was 
with a 2.0 L/min gas flow. 2.0 L/min has proven to work well since the signal is stable and the 
intensity is high. 
Above all, we are interested in the best parameters for SUMO peptides. To this effect, we 
infused a solution with 5 synthetic SUMO 3 peptides (200 fmol/µl). The temperature of the inner 
electrode was 70°C and the outer electrode 90°. As usual, the dispersion voltage was set at -
5000V and the ionisation of the spray was set at 3.60 kV. The signal intensity for each individual 
ion was taken on the optimal CV. All of the SUMO 3 peptides can appear in different charge 
states.  
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Table 8: Follow list shows the m/z value of the 5 peptides as 2+ and 3+ precursor ions. 
392.54
3+
 588.30
2+
 450.57
3+
 675.35
2+
 477.93
3+
 716.40
2+
 557.60
3+
 835.89
2+
 647.39
3+
 970.50
2+
 
 
The gas flow rates of 1.5 – 2.0 – 2.5 – 3.0 and 3.5 L/min were tested. There seems to be an 
increase in intensity for the triple charge peptides at higher flow rate and the opposite for the 
doubly charged peptides. However this difference does not really have an impact. Out of 
curiosity and to confirm this observation we did the same with a digested solution of BSA and 
obtained the same trend. 
 
 
Figure 29: Intensity for the 5 SUMO3 peptides for different gas flow rate. Left the ion has charge 3, right as 
double charge ion. 
 
3.1.2. TEMPERATURE 
As mentioned for the flow rate tests, we were using the standard parameter and changed 
only the temperature of the electrodes. For the parameter experiments we were scanning over 
a CV range from -95V to -15V. In addition to the intensity of the ions, resolution between 
peptides is another important aspect. If the CV values for the optimal intensity are the same, the 
peptides co-elute. When we tested different temperature combinations we observed this effect 
more for doubly charged peptides. A better resolution can be achieved if the temperature is 
increased between the electrodes.  
To illustrate the effect of the temperature on the intensity we plotted the different 
temperature combinations against the ion intensity. 
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Figure 30: The 5 different intensity profiles for 
different electrode temperatures 
We get similar profiles for each 
SUMO3 peptide and there is no significant 
difference. However, it seems that the 
intensity for the triply charged ions in FAIMS 
is better. It becomes apparent that the ratio 
of the 3+ to 2+ ion increase with higher m/z 
value. 
 
The result tells us that the combination of IE 70°C – OE 90°C is a good choice. The 
Intensity is more or less the same for all peptides compared to other combinations and we also 
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have good transmission for the 3+ and 2+ ions. Figure 30 shows a better transmission of the 
triply charged form of the peptide than for the corresponding doubly charged ions. To 
summarize, FAIMS has a better transmission and separation of ions for charges states > 2+ 
(delta CV is larger). 
3.1.3. DISPERSIONS VOLTAGE 
 
Figure 31: The influence of the DV voltage shows a huge loss of intensity at lower voltages. The results of the 
graph bellows were obtained at gas flow 2.0L/min and IE70 ̊C – OE 90 ̊C.  
 
Different dispersion voltages show that the best DV is at -5000V. The transmission of ions 
is most effective when the amplitude of the waveform cycle is at its maximum. 
3.1.4. ACETONITRILE 
Usually, FAIMS is conducted with inert nitrogen gas. It has been reported that gas 
modifiers like acetonitrile or ethanol improve sensitivity by increasing signal intensity (22). This 
is due to the cluster effect between the peptides in the gas phase. Even if we couldn’t add 
modifiers to our gas source, we were using different concentrations of acetonitrile for the 
dilution (only infusion) but we noticed no significant difference. This proves that the sole 
addition of organic solvent is not enough for declustering peptides in the gas phase. 
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3.2. COMPARISON OF LC-MS WITH AND WITHOUT FAIMS 
Equal amount of digested tryptic HEK293 total lysate were injected with FAIMS (12 CV 
steps) and without FAIMS (12 replicate).  
a) 
 
b) 
 
 
 
-28V/-30V 
 
-32V/-34V 
 
-36V/-38V 
 
-40V/-42V 
 
-44V/-46V 
 
-48V/-50V 
 
-52V/-54V 
 
-56V/-58V 
 
-60V/-62V 
 
-64V/-66V 
 
-68V/-70V 
 
-72V/-74V 
 
c) 
 
d) 
 
 
Figure 32: TIC LC-MS Chromatogram without FAIMS (a) for the 12 replicates and with FAIMS (b) for the 12 CV 
steps. The peptide map of RT versus m/z for all identified peptide ions without FAIMS (c) and with FAIMS (d). 
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As observed in figure 32, the total ion chromatograms without FAIMS (a) are all similar for 
the different replicates. With FAIMS (b) we see a change of transmitted ions for the different CV 
ranges. By comparing figure 32 c) and d) we can see a denser peptide ion population for the CV 
stepping with FAIMS located in the lower m/z range. This indicates a higher charge state for 
peptide ions as supported with the greater amounts of the 3+ and 4+ peptide ions for FAIMS. 
The following table summarizes the number of identified peptide ions in function of their 
charge. 
Table 9: Summary identified peptides ions in function of their charge 
Ion charge 2+ 3+ 4+ 
without FAIMS 4162 1392 207 
with FAIMS 7623 1894 380 
 
With FAIMS we have a markedly higher score on identified peptides ions compared to no 
FAIMS. Not only do we detect a large number of doubly charged peptides, but also a significant 
increase of triply charged peptides. For the 4+ population we have noted a decrease of 46% 
without FAIMS. To have an idea of the intensity range in which we detect these peptide ions, we 
can look at the distribution of the ions as a function of their signal intensity. 
a) 
 
b) 
 
Figure 33: Left plot shows frequency of identified peptide ions belonging to a population of tryptic peptides of 
HEK293 total cell lysate in function of their intensity with FAIMS and without FAIMS (a). On the right site the intensity 
of the common peptides with FAIMS and without FAIMS are plotted (b). 
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The peptides with identical sequence but different PTM modification and charge state are 
counted individually. As can be seen in figure 33, FAIMS identified more peptide ions, especially 
peptides of low intensity. Indeed we are able to identify a larger population of ions with low 
abundance because of the increase of the signal to noise ratio. Furthermore we have no loss of 
intensity, since 88% of all common peptide ions record less than 30% intensity variation. The 
scatter plot shows that a major part of all ions are lined up on the diagonal. In this area the 
intensity with FAIMS and without FAIMS are equal.  
When we look at the number of new unique peptides after each injection (figure 34 a), we 
notice a two-fold higher score for identified peptides with FAIMS after 12 injections. The right 
graph below shows in how many injections we identified the same peptide ion. 
a) 
 
b) 
 
Figure 34: Left (a): number of unique peptide after each injection or CV range. Right (b): How many times we 
identified the same precursor ion 
 
It is noteworthy that FAIMS transmits about 50% more peptides. Additionally, with FAIMS, 
starting from the third injection, we identify more peptides than without FAIMS. While we 
observe without FAIMS a plateau after the fourth replicate, it seems that for FAIMS the slope is 
positive even after the twelfth CV range. Figure 34 b shows that the same transmitted peptides 
are not detected more than 3 times in different CV ranges for FAIMS. The majority of them are 
identified only once while we recorded multiple identification without FAIMS. 
Finally, in this experiment we found 8260 unique peptides corresponding to 1165 proteins 
with the 12 CV scanning method of FAIMS and 4820 peptides (734 proteins) for replicate 
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injections without FAIMS. The number of protein and peptides shown in the figure below 
include the 1.0% false discovery rate and do not differ between the different charged states. 
 
a)
 
b) 
 
Figure 35: Venn diagram showing identified unique and common peptides (a) as well the proteins (b) resulting 
from a tryptic digest of HEK293 protein extracts. Analysis was done without FAIMS (12 replicates) and with FAIMS (12 
CV steps between -28V and -74V). FDR for proteins and peptides are at 1%. 
 
The non-overlapping areas of the identified common peptides correspond to the unique 
peptides detected with FAIMS and without FAIMS. These are 34% and 58% of all peptides for 
FAIMS and without FAIMS, respectively. The overlapping area for FAIMS is only a small fraction 
of the total and this highlights its performance at different CV ranges. FAIMS is able to transmit 
more peptide ions to increase peptide identification. To identify peptides, bioinformatics tools 
compare the MS/MS spectrum with the database spectrum. Because of the low signal to noise 
ratio of precursor ions, many MS/MS spectra without FAIMS were not acquired. The peptide 
identification is missing. But we also observe unique peptides upon analysis with FAIMS. There 
are various reasons for the absence of peptides in FAIMS. First, the transmission of an ion is over 
3V (23), but we are not able to detect all ions at the peak top and the tandem mass spectrum 
cannot be recorded because of the low intensity of the signal. Then it can be that the cycle of 
the orbitrap is saturated with ions and no more ions are transmitted. This may explain the 
unique peptides found only without FAIMS. Moreover we were scanning only over a limited CV 
range from -28V to -74V. Ions with other CV were not transmitted. For the proteins, 42% of the 
total identified proteins were identified with FAIMS compared to the 8% identified without 
FAIMS. Even if we miss some peptides with FAIMS, we cover almost all proteins without FAIMS. 
Furthermore we are able to identify much more.  
2031 
unique peptides 
found  
without FAIMS 
2789 
common  
peptides 
5471 
unique peptides 
found  
with FAIMS 
98 
unique proteins 
found  
without FAIMS 
636 
common  
proteins 
529 
unique proteins 
found  
with FAIMS 
Identification of SUMOylation Sites using High-Field Asymmetric Waveform Ion Mobility (FAIMS) coupled to a Linear Ion Trap/Orbitrap Mass Spectrometer 
Sibylle Pfammatter 
 
|42 
When we are looking on a MS spectrum of a unique peptide identified only by FAIMS, we 
observe a significant increase of the signal to noise ratio. The following is an example of a 
spectrum for the triply charged peptide RDQDNMQAELNR corresponding to the precursor ion 
m/z 497.23 3+. This peptide ion was identified only with FAIMS. 
a)
 
b)
 
c)
 
 
Figure 36: MS of precursor ion m/z 497.23 
3+
 with FAIMS (a) and without FAIMS (c). The right spectrum (c) 
corresponds to the MS/MS fragmentation of RDQDNMQAELNR with FAIMS. 
 
It is clear that without FAIMS the signal of the precursor ion m/z 497.23 3+is undermined 
by the higher abundance of other precursor ions, while in FAIMS analysis a higher S/N ratio is 
obtained. These results demonstrate the capacity and efficiency obtainable with FAIMS. The 
number of identified peptides ions is significantly higher because the samples were fractionated 
and simplified. The signal to noise ratios increase and more ions can be transmitted by FAIMS. 
This allows for an improvement in large-scale proteomics studies.  
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The comparison nano-LC-FAIMS-MS/MS with nano-LC-MS/MS for SUMO target was done 
with synthetic SUMO peptides that were spiked in total HEK293 cell lysates (see 2.7). 
a) 
 
b)
 
 
 
-34V-37V-40V 
 
 
-43V-46V-49V 
 
 
-52V-55V-58V 
 
 
-61V-64V-67V 
 
 
-70V-73V-76V 
 
 
-79V-82V-85V 
c) 
 
d)
 
 
Figure 37: TIC LC-MS Chromatogram for 4 pmol synthetic SUMO peptides spiked in HEK293 without FAIMS (a) 
and with FAIMS at 6 different CV ranges(b). Below the peptide map of RT versus m/z for all identified peptide ions 
without FAIMS (c) and with FAIMS (d). 
 
The total ion chromatogram for FAIMS application shows the same tendency as shown 
previously. Interestingly, we identified a strikingly larger population of all SUMO peptides with 
FAIMS at the charge state 3+ in peptide maps. This is not the case without FAIMS, where there 
were huge populations on 2+ SUMO peptides ions with a higher m/z value. 
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If we look at the CV range of the identified SUMO precursors compared to the tryptic 
digest of HEK293, we can observe a shift in the measured CV range. The histograms below 
distinguish between the charge states of identified peptide ions. 
 
a) 
 
b) 
 
Figure 38: Stacked histogram for tryptic population compared to synthetic SUMO peptides in a compensations 
voltage range from -28V to -85V. 
 
The SUMO peptides are idenified at a higher CV range. This allows us to identify SUMO 
targeted peptides. We can separate the low abundance SUMO peptides from the complex 
HEK293 population without an additional handling step. Extra sample preparation steps could 
induce loss and increase the risk of contamination. It was also observed that tryptic peptide ions 
have lower charged states while SUMO peptides were mostly triply charged. The CV distribution 
helped in the selection of peptides and facilitated the idenfication of SUMOylated sites when a 
characteristic CV range was used. A CV range of -64V and higher allows for better identification 
of SUMO targets. 
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3.3. ENHANCEMENT OF SENSITIVITY WITH FAIMS 
As indicated, the aim of this study is to improve the sensitivity for the identification of 
SUMO targets. We were looking for the ideal limit of detection for identifying synthetic SUMO 
peptides with and without FAIMS. For this, we injected different concentrations of synthetic 
SUMO peptides to determine the linear dynamic range. The following example illustrates the 
synthetic peptide TSDADIKSSETGAFR conjugated to either SUMO 1 or SUMO 3. 
a) 
 
a-SUMO1) 
 
a-SUMO3) 
 
b) 
 
b-SUMO1)  
 
b-SUMO3) 
 
Figure 39: The peptide TSDADIKSSETGAFR was synthetized with the modification SUMO 1 (residue EQTGG) and 
SUMO 3 (residue NQTGG). The linearity curve without (a) and with (b) FAIMS are on the left site. On the right side the 
MS spectres of the precursor ions correspond to the lowest concentration of detected ions. Without FAIMS we 
detected SUMO 1 and SUMO 3 at m/z 1029.4385 
2+
 and m/z 1021.9729 
2+
 respectively. With FAIMS we detected m/z 
684.9922 
3+
 and 681.6469 
3+ 
precursor ions. 
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With and without FAIMS we get a linear range, even if the SUMO 1 peptide shows a lower 
intensity. Without FAIMS the precursor ions were detected as doubly charged ions, while with 
FAIMS they were detected as triply charged ions. However, although the MS spectra at higher 
m/z for 1029.4385 2+ and 1021.9729 2+ are less complex, we have an increase of signal 
intensity compared to the neighbouring ions with FAIMS for the triply charged ions 684.9922 3+ 
and 681.6469 3+. The above figure shows a limit of detection of 217 fmol for SUMO 1 (S/N 1 @ 
100 fmol) and 213 fmol for SUMO 3 (S/N 3 @ 200 fmol) without FAIMS. With FAIMS the LOD are 
19 fmol for SUMO 1 (S/N 3 @ 20 fmol) and 5 fmol for SUMO 3 (S/N 55 @ 100 fmol). Thus it 
appears that FAIMS is able to detect low abundance peptides and the linear range starts at low 
concentrations. 
To summarize all obtained results, LOD values without FAIMS are plotted against FAIMS.
 
Figure 40: Limit of detection obtained from synthetic SUMO peptides spiked in digested HEK293 total lysat. 
LOD values obtained by FAIMS are plotted against LOD without FAIMS 
 
Most often, we get a lower limit of detection with FAIMS. FAIMS compared to no FAIMS is 
on average 18 times more sensitive. This was expected from the literature (2) and our results 
confirm it. For FAIMS we were at an average limit of detection of 12 fmol compared to 183 fmol 
without FAIMS. Data obtained from this experiment and previous experiments, help us in 
improving the detection of SUMO target sites in samples.   
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3.4. HEAT SHOCK HEK293-SUMO 3 
80 million cells per condition were cultured for the large-scale experiment. This 
corresponds to 32 mg proteins (16 mg nucleus and 16 mg cytoplasm). After Ni-NTA purification, 
100 µg of nuclear proteins were purified. 
3.4.1. WESTERN BLOT ANALYSIS 
If antibodies are available, western blot is a favored method to validate and confirm the 
results before injecting on the mass spectrometer. In our case, we observed the changes caused 
by the heat shock and monitored the changes in the enrichment of SUMO peptides. For the heat 
shock, we wanted to investigate the trend of sumoylation over a time range. In the paper from 
Knejzlik and Co. maximal accumulation of SUMOylation was found to be after 45 min at 42°C 
(24). In our case, the heat shock of HEK293 mutant SUMO3 cells was done at 43°C. 
 
 
Figure 41: The effects of heat shock (43°C) on HEK293 SUMO3 cells over an 8hr period. 
 
In the first experiment we were looking for cell response to heat in the form of 
SUMOylation. To study this, time points between 0 to 8 hours were taken. The trend shows a 
maximum of response after 60 minutes as well as at 8 hours in the nucleus. For the cytoplasm, 
an early accumulation followed by a decrease in SUMOylated proteins can be observed. For the 
loading control, we got similar signals for alpha tubulin and histone in all fractions and this 
shows that the nucleus and the cytoplasm were efficiently separated. We can also see that the 
SUMO peptides are more enriched in the nucleus. For Ni-NTA purification (6.3) a heat shock of 
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one hour was used. Increased SUMOylation was at both 45 and 60 minutes. During the mass 
spectrometry analysis, we injected only the nuclear fraction.  
3.4.2. MASS SPECTROMETRY ANALYSIS 
Based on the previously mentioned results, 4 replicates were injected without FAIMS. 
After 4 replicates found no new peptides. With FAIMS the CV range from -36V to -82V was over 
scanned. The samples were prepared as descripted in paragraph 2.2 of the methods section. For 
the LC-MS/MS analysis, a 20 cm long analytical column with a C18 stationary phase was used 
with a gradient performed of 120 min. As shown by the Western Blot (point 6.3), the amount of 
SUMOylated peptides is weak.  
Table 10: Identified SUMO3ylated peptides for heat shock experiment 
FAIMS noFAIMS 
0 min 60 min 0 min 60 min 
APGVANKKIHLVVLVKPSGAR 
ANEKPTEEVKTENNNHINLKVAGQDG
SVVQFK 
 
ANEKPTEEVKTENNNHINLK 
EGVKTENDHINLK ATMHLKQEVTPR 
 
IVHQSLNIMNSFSQKVKIQQIRSLSEDV
R 
KKGAMEELEKALSCPGQPSNCVTIPR EGVKTENDHINLK 
 
KVIKMESEEGKEAR 
LQEKLSPPYSSPQEFAQDVGR KDDGENAKPIKK 
 
NTELKKLQIFGAGPKVVGLAMGTK 
MKTENLKKR KDQLITKCNEIESHIIK 
  
 
KKEPPKELR 
  
 
KVIKMESEEGKEAR 
  
 
LKSAQCGSSIIYHCKHK 
   
Finally, we identified 12 SUMO sites in total for FAIMS (5151 unique peptides) and 4 
without FAIMS (4045 unique peptides). A higher signal to noise ratio for the identified peptides 
with FAIMS was observed. The separation was done only in a 1D LC system. There were several 
reasons for this. In a recent published paper from Vertegaal and Co. (25) they used a 1D LC 
method for the identification of SUMOylation sites. In addition, during the injection of the 
Promix solution in a 1D LC system compared with the 2D LC system, we lost a lot of transmission 
(the intensity was 2times less with 2D LC than 1D LC). Unfortunately we can only load 1 µg 
proteins on a 1D LC system compared to up to 3 µg on the 2D LC system. The fact that SUMO 
proteins are present less than 1% in a cell (26) limits the success of direct identification from 
complex mixtures without effective enrichment of SUMO peptides, like with 
immunoprecipitation. The low number of SUMOylated proteins is also due to the fact that we 
did only used one biological replicate as well as only one technical replicate. The probability of 
identifying more SUMO peptides with different replicates increases significantly after one 
replicate. However, we could only show that the identification of SUMO peptides was higher for 
nanoLC-FAIMS-MS than for nanoLC-MS.   
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4. Conclusion 
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Preliminary experiments using FAIMS with 5 synthetic SUMOylated peptides showed an 
optimized parameter for a better transmission and resolution for the triply charged peptides at 
a higher CV range as well as a more stable signal. FAIMS benefits from this high performance 
and allows for protein identifications without the loss of any signal intensity. We also showed 
that the number of synthetic SUMO peptides had limit of detection 15 times lower with FAIMS 
than without FAIMS. Moreover, the triply charged state for SUMOylated peptides is the most 
favourable form. The specific CV range distribution of SUMO peptides facilitate their detection 
when present in complex tryptic digests of HEK293 cell extracts. Finally, we demonstrated that 
there is an accumulation of SUMOylation in cells that undergo a heat shock treatment and we 
were able to identify twice the amount of SUMOylated peptides with FAIMS than without 
FAIMS.  
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6.1. UNIPROT DATA’S SUMO PROTEINS 
Table 11: Cleave sites for SUMO isoforms by tryptic digestion 
SUMO1_HUMAN (P63165) from 
UniProtKB/Swiss-Prot 
SUMO2_HUMAN (P61956)from 
UniProtKB/Swiss-Prot 
SUMO3_HUMAN (P55854) from 
UniProtKB/Swiss-Prot 
 
  
 
6.2. LIMIT OF DETECTION 
Table 12: List of LOD values for SUMO spiked in HEK293 
 
CV 
SignalBac
kground 
MSn 
Signal 
MSn 
conc conc LOD LOQ 
factor 
SignalBac
kground 
MSn 
Signal 
MSn 
conc conc LOD LOQ 
 
FAIMS     pmol fmol fmol noFAIMS   pmol fmol fmol 
AFITNIPFDVKWQSLK -49 2.3E+03 1.1E+04 0.02 12 41 35 1.6E+04 4.3E+04 0.40 434 1445 
APGQHGGFVVTVKQER -49 3.1E+03 6.7E+04 0.10 14 46 10 1.1E+04 2.4E+04 0.10 139 464 
APTASQERPKEELGAGR -43 1.7E+03 3.3E+04 0.02 3 10 19 1.1E+04 5.5E+04 0.10 59 197 
AYQKQPTIFQNK -73 1.4E+03 2.8E+03 0.02 30 101 4 1.1E+04 5.8E+04 0.20 112 374 
EGVKTENDHINLK -64 6.8E+02 2.4E+03 0.02 17 112 5 1.0E+04 3.7E+04 0.10 83 275 
EKLEMEMEAAR -73 1.2E+03 6.3E+03 0.02 12 40 5 9.7E+03 9.1E+04 0.20 64 214 
EKLTADPDSEIATTSLR -49 1.8E+03 1.3E+04 0.02 8 28 1 2.0E+04 8.9E+05 0.10 7 23 
ELSEVKNVLEK -67 1.7E+03 1.3E+04 0.02 8 25 6 1.0E+04 6.9E+04 0.10 45 149 
EMSGSTSELLIKENK -40 2.1E+03 4.0E+04 0.10 16 53 16 1.6E+04 3.9E+04 0.20 253 842 
FQIIKQEPMELESYTR -46 2.8E+03 4.8E+04 0.02 3 11 59 2.5E+04 7.3E+04 0.20 202 674 
HHSLALTSFKR -67 3.0E+03 8.2E+04 0.10 11 37 7 1.7E+04 6.8E+04 0.10 76 255 
HTPLSKLMK -49 2.9E+03 2.8E+04 0.20 63 210 1 9.0E+03 5.9E+04 0.10 46 153 
IESESKGIKGGK -52 1.8E+03 1.4E+05 0.02 1 3 228 4.4E+03 7.4E+03 0.10 179 596 
IFDEEPANGVKIER -43 1.8E+03 6.0E+03 0.02 18 60 20 1.8E+04 3.1E+04 0.20 361 1203 
IGAIKQESEEPPTK -61 1.9E+03 2.2E+04 0.02 5 17 60 1.5E+04 2.8E+04 0.20 312 1041 
IIVDELKQEVISTSSK -52 1.9E+03 5.5E+03 0.02 21 69 15 2.0E+04 3.9E+04 0.20 312 1039 
IKDEPDNAQEYSHGQQQK -52 1.3E+03 1.0E+04 0.02 8 25 17 9.8E+03 2.3E+04 0.10 130 433 
IKEDDAPR -70 1.3E+03 3.9E+04 0.02 2 7 24 6.0E+03 3.7E+04 0.10 49 164 
IKSGEVAEGEAR -76 1.2E+03 7.1E+04 0.02 1 3 48 1.1E+04 6.9E+04 0.10 49 162 
IKVEPASEKDPESLR -58 1.8E+03 4.5E+04 0.02 2 8 35 1.4E+04 5.1E+04 0.10 83 278 
INEILSNALKR -67 2.6E+03 5.7E+04 0.10 14 46 104 3.7E+04 1.5E+05 2.00 1449 4830 
KDDEVQVVR -64 1.8E+03 5.9E+04 0.10 9 30 8 6.5E+03 2.6E+04 0.10 74 246 
KNAALVTR -79 5.6E+02 9.4E+03 0.02 4 12 18 6.4E+03 2.9E+04 0.10 66 219 
KVEEDEAGGR -85 1.9E+03 7.3E+04 0.02 2 5 17 3.8E+03 4.2E+04 0.10 27 91 
LKEDVLEQR -73 1.6E+03 2.4E+04 0.02 4 13 4 9.7E+03 1.8E+05 0.10 16 54 
LLVHMGLLKSEDK -43 1.7E+03 1.6E+04 0.02 6 21 12 1.1E+04 8.6E+04 0.20 79 262 
MKFNPFVTSDR -85 1.4E+03 3.3E+04 0.02 3 8 24 1.8E+04 8.7E+04 0.10 62 208 
MNKSEDDESGAGELTR -55 1.6E+03 9.0E+03 0.02 11 36 12 1.1E+04 2.8E+04 0.10 124 414 
NISIKQEPK -67 1.6E+04 1.6E+05 0.10 29 98 8 1.1E+04 1.5E+05 1.00 222 741 
NLLHDNELSDLKEDKPR -64 1.7E+03 4.5E+03 0.02 22 75 1 1.2E+04 2.3E+05 0.10 16 52 
NLYKNVILENYR -52 1.7E+03 9.7E+03 0.02 10 35 0 1.5E+04 2.2E+05 0.02 4 14 
NSIDASEEKPVMR -55 1.4E+03 4.0E+03 0.02 21 69 7 8.9E+03 3.9E+04 0.20 138 459 
QFNKLTEDK -73 1.3E+03 6.3E+03 0.02 13 43 5 1.4E+04 6.6E+04 0.10 62 206 
SAEEVEEIKAEK -52 1.8E+03 2.1E+04 0.02 5 17 22 1.5E+04 3.9E+04 0.10 113 376 
SGLKHELVTR -67 1.5E+03 1.7E+04 0.02 5 18 13 8.3E+03 3.6E+04 0.10 69 231 
STPKEETVNDPEEAGHR -46 2.1E+03 2.0E+04 0.02 6 21 24 8.9E+03 1.8E+04 0.10 151 504 
STYADEELVIKAEGLAR -34 2.3E+03 3.1E+04 0.20 45 151 24 2.2E+04 6.0E+04 1.00 1084 3613 
SVHSQDPSGDSKLYR -52 2.2E+03 1.9E+04 0.02 7 23 39 9.4E+03 2.1E+04 0.20 274 913 
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TDLDDDITALKQR -49 2.1E+03 2.7E+04 0.02 5 15 38 1.7E+04 2.9E+04 0.10 175 584 
TKPDPEVEEQEK -73 1.2E+03 7.0E+03 0.02 10 34 5 9.9E+03 5.8E+04 0.10 51 171 
TLAEIAKVELDNMPLR -43 1.9E+03 2.3E+04 0.02 5 17 20 3.0E+04 9.2E+04 0.10 99 329 
TLSDYNIQKESTLHLVLR -58 2.7E+03 1.2E+05 0.10 7 23 34 2.4E+04 6.0E+04 0.20 238 794 
TSDADIKSSETGAFR -70 1.7E+03 9.6E+04 0.10 5 18 39 1.6E+04 4.4E+04 0.20 213 711 
TVTITKEDESTEK -67 1.7E+03 1.5E+04 0.02 7 24 7 8.4E+03 5.0E+04 0.10 51 169 
VGEPEVKEEK -64 1.3E+03 2.3E+04 0.02 4 12 15 1.3E+04 7.7E+04 0.10 52 174 
VKEDPDGEHAR -52 3.3E+03 3.2E+04 0.02 6 21 35 3.6E+03 9.9E+03 0.20 214 714 
VKEEHLDVASPDK -76 6.6E+03 1.2E+05 0.10 16 54 3 1.1E+04 6.5E+04 0.10 50 165 
VKFEQNGSSK -85 6.6E+02 1.8E+04 0.02 2 7 126 9.1E+03 3.9E+04 0.40 284 946 
VKLDSVR -85 2.3E+03 2.2E+04 0.02 6 21 17 1.3E+04 7.3E+04 0.20 106 354 
VLLGETGKEK -73 1.9E+03 6.4E+04 0.02 2 6 63 1.7E+04 8.9E+04 0.20 114 379 
VNLDSEQAVKEEK -52 1.9E+03 2.2E+04 0.02 5 17 16 1.5E+04 5.5E+04 0.10 81 272 
VQIKQETIESR -70 1.3E+03 2.4E+04 0.02 3 11 44 1.0E+04 2.1E+04 0.10 146 485 
VSISEGDDKIEYR -55 1.9E+03 1.2E+04 0.02 9 31 4 1.0E+04 7.9E+04 0.10 39 130 
VVHIDSGIVKQER -55 2.7E+03 4.1E+04 0.02 4 13 11 1.3E+04 8.4E+04 0.10 45 150 
WTVVKTEEGR -67 2.0E+03 4.5E+04 0.02 3 9 115 2.9E+04 2.8E+04 0.10 302 1008 
YEEALSQLEESVKEER -40 2.1E+03 1.1E+04 0.02 11 38 1 1.5E+04 6.8E+04 0.02 13 44 
YQKSTELLIR -85 8.6E+02 5.0E+04 0.02 1 3 29 1.2E+04 1.2E+05 0.10 30 101 
ADSVGKLVTVR -58 1.8E+03 5.4E+04 0.02 2 7 27.0 2.3E+04 7.8E+04 0.20 177 591 
AEAMNIKIEPEETTEAR -52 2.2E+03 1.4E+04 0.10 46 152 0.8 2.9E+04 1.4E+05 0.20 127 422 
APPNVKNEGPLNVVK -70 2.7E+03 1.0E+04 0.02 16 53 2.8 2.1E+04 8.6E+04 0.20 147 489 
DGDVVLPAGVVVKQER -43 1.8E+03 3.3E+04 0.10 17 55 6.5 2.7E+04 4.6E+04 0.20 356 1188 
DTSKMYIPHTDK -61 4.2E+03 5.0E+04 0.10 25 85 1.3 2.3E+04 1.3E+05 0.20 109 365 
EDEGFIKEEEKPLPR -52 2.4E+03 3.6E+04 0.10 20 67 3.1 2.1E+04 6.1E+04 0.20 205 682 
EMSGSTSELLIKENK -40 2.1E+03 1.2E+04 0.02 11 36 1.1 3.1E+04 4.6E+05 0.20 40 132 
HIDALEDKIDEEVR -61 3.0E+03 1.7E+04 0.02 11 35 10.1 3.3E+04 5.5E+04 0.20 356 1185 
IFDEEPANGVKIER -43 1.7E+03 5.8E+03 0.02 18 60 0.9 2.1E+04 2.3E+05 0.20 53 177 
IKEEEEGAEASAR -34 7.9E+02 7.6E+03 0.10 31 105 1.2 5.5E+03 1.3E+04 0.10 123 410 
IKTEPLDFNDYK -64 2.1E+03 1.2E+04 0.02 11 35 3.1 4.2E+04 2.3E+05 0.20 110 366 
IKVEPASEK -58 8.5E+03 6.3E+04 0.02 8 27 4.9 5.6E+03 1.3E+04 0.10 133 442 
INEILSNALKR -70 1.4E+03 4.2E+04 0.10 10 34 2.6 4.8E+04 3.3E+05 0.20 87 290 
KANLLR -55 1.1E+04 2.4E+05 0.02 3 9 29.6 1.6E+04 7.2E+04 0.40 260 866 
KGFSEGLWEIENNPTVK -46 3.5E+03 5.4E+04 0.02 4 13 13.7 1.8E+04 6.0E+04 0.20 179 597 
KYYYYER -85 1.4E+03 5.2E+03 0.02 16 55 2.1 5.4E+03 2.9E+04 0.20 113 375 
LKSVAK -46 1.5E+03 2.3E+04 0.02 4 13 6.6 4.9E+03 3.4E+04 0.20 87 289 
LLLGSPSSLSPFSKR -49 1.6E+03 7.7E+03 0.02 13 42 0.3 1.4E+04 6.4E+04 0.02 13 43 
LLVHMGLLKSEDK -43 2.5E+03 1.3E+06 0.02 0.1 0.4 13.6 2.0E+04 2.4E+05 0.02 5 17 
LQTMKEELDFQK -52 2.6E+03 1.4E+04 0.02 11 36 1.0 1.7E+04 2.8E+04 0.02 36 121 
MAVKEEK -70 1.2E+03 1.6E+04 0.02 4 14 3.7 8.3E+03 4.7E+04 0.10 53 178 
MNKSEDDESGAGELTR -55 1.4E+03 2.6E+03 0.02 33 111 2.3 2.1E+04 4.9E+04 0.20 255 851 
NEGPLNVVKTEK -52 4.2E+03 5.1E+04 0.02 5 16 7.7 1.6E+04 7.4E+04 0.20 127 425 
NKEIMYR -85 2.2E+04 4.8E+04 0.02 28 92 2.4 1.3E+04 3.5E+04 0.20 226 754 
NSDIEQSSDSKVK -34 1.7E+03 1.4E+04 0.10 37 125 1.0 6.2E+03 1.5E+04 0.10 127 423 
QFNKLTEDK -79 2.6E+03 9.9E+04 0.10 8 26 1.7 8.0E+03 5.3E+04 0.10 45 150 
QSLKQGSR -76 1.3E+03 5.0E+04 0.10 8 27 3.0 8.8E+03 3.3E+04 0.10 80 267 
SAEEVEEIKAEK -49 2.3E+03 3.5E+04 0.02 4 13 4.7 8.6E+03 4.2E+04 0.10 62 207 
SDQDHSMDEMTAVVKIEK -49 1.5E+03 2.9E+03 0.02 32 106 2.8 2.2E+04 4.5E+04 0.20 293 978 
SMSVEKIDISPVLLQK -61 2.5E+03 2.4E+04 0.10 32 105 0.1 1.6E+04 7.0E+04 0.02 13 45 
SSIKQEPIER -64 1.4E+03 3.6E+04 0.02 2 8 42.3 1.5E+04 2.7E+04 0.20 333 1109 
STIKTDLDDDITALK -61 1.6E+03 7.0E+03 0.02 13 45 13.3 3.3E+04 3.3E+04 0.20 593 1976 
TDLDDDITALKQR -49 2.1E+03 1.0E+04 0.02 13 42 8.4 1.0E+04 1.8E+04 0.20 353 1175 
TFNSELYSLNDYKPPISK -43 2.0E+03 5.4E+04 0.10 11 37 1.5 2.7E+04 1.5E+05 0.10 55 182 
TFSESLKSEK 82 5.7E+03 9.6E+04 0.02 4 12 15.8 2.0E+04 6.2E+04 0.20 189 629 
TKAEEPSDLIGPEAPK -52 1.9E+03 2.6E+04 0.02 4 15 2.2 1.7E+04 3.1E+05 0.20 33 110 
TKPDPEVEEQEK -67 1.8E+03 6.5E+04 0.02 2 6 37.2 1.2E+04 3.4E+04 0.20 210 700 
TLAEIAKVELDNMPLR -46 
      
2.4E+04 3.5E+04 1.00 2017 6723 
TSDADIKSSETGAFR -70 1.8E+03 5.4E+03 0.02 19 65 3.3 2.3E+03 3.2E+03 0.10 217 724 
TVTITKEDESTEK -64 1.3E+03 2.9E+04 0.02 3 9 10.4 2.8E+03 8.8E+03 0.10 97 323 
VENGQEPVIKLENR -49 1.8E+03 2.9E+04 0.02 4 12 8.9 1.3E+03 3.5E+03 0.10 110 367 
VGVKSAPR -67 5.5E+03 1.4E+05 0.02 2 8 5.8 4.8E+03 3.2E+04 0.10 45 149 
VIKMESEEGK -76 1.4E+03 9.6E+04 0.02 1 3 9.8 3.1E+03 3.2E+04 0.10 29 96 
VKEDPDGEHAR -49 1.6E+03 7.2E+05 0.02 0.1 0.4 17.9 1.0E+04 7.6E+04 0.02 8 27 
VKVEEEEEEK -79 1.7E+03 6.9E+04 0.02 2 5 4.7 7.3E+03 9.3E+04 0.10 24 78 
VLDLELKGDIEK -73 9.5E+02 1.9E+03 0.02 30 99 9.4 2.4E+04 7.7E+04 1.00 932 3107 
VLLGETGKEK -61 8.7E+03 1.7E+05 0.10 16 52 1.7 4.5E+03 1.6E+04 0.10 86 288 
VNLDSEQAVKEEK -52 1.5E+03 1.1E+04 0.02 9 28 9.3 1.2E+04 5.4E+04 0.40 263 875 
VVHIDSGIVKQER -40 3.4E+03 3.3E+04 0.10 31 102 0.6 9.9E+03 4.6E+04 0.10 64 214 
WMKHEPGLGSYGDELGR -58 1.6E+03 1.2E+04 0.02 8 28 23.3 3.2E+04 5.9E+04 0.40 641 2137 
YKWEYTYYSR -58 2.2E+03 7.3E+03 0.02 18 59 3.0 1.2E-04 2.1E+04 0.10 173 578 
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Figure 42: Comparison LOD for pure synthetic SUMO peptides or when spiked in HEK293 cell lysat. 
 
 
 
 
Figure 43: R
2
 values of linearity for the common SUMO 1 (left) and SUMO 3 (right) peptides 
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6.3. HEAT SHOCK 
 
 
Figure 44: Western blot after purification on NiNTA beads. The heat shock was performed on the time points 0 
- 10 - 20 -30 -45 - 60 minutes at 43 °C 
 
 
 
Figure 45: Western Blot against antibody SUMO 2. After NiNTA enrichment the response on the western blot is 
less. There is no loss of SUMOs on the pulldown after NiNTA incubation. 
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6.4. SUMO 1 AND SUMO 3 SYNTHETICS 
Table 13: List of the 96 SUMO 1 peptides synthetic par PJG Berlin 
Sequences synthesized 
C-
terminus 
Comments 
Length w/o 
C-term 
Synthesis-# Plate-# Row Column 
Amount/Well 
[nmol] 
sequence 
Peptide 
SUMO 
Peptide 
ALPPEVaVEGP K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys A 1 60 ALPPEVKVEGPK 1735.92 1263.731 
APPNVaNEGPLNVV K a=Lys(EQTGG) 16 2438_4a 2438_4a Lys A 2 60 APPNVKNEGPLNVVK 2048.08 1575.885 
DCPIaEE K a=Lys(EQTGG) 9 2438_4a 2438_4a Lys A 3 60 DCPIKEEK 1433.66 961.4659 
DGIEPMWEDEaN K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys A 4 60 DGIEPMWEDEKNK 2062.90 1590.71 
DGLa K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys A 5 60 DGLKK 1032.53 560.3402 
DaSS K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys A 6 60 DKSSK 1036.49 564.2988 
DTSaMYIPHTD K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys A 7 60 DTSKMYIPHTDK 1907.88 1435.689 
EDFIELCTPGVIaQE K a=Lys(EQTGG) 17 2438_4a 2438_4a Lys A 8 60 EDFIELCTPGVIKQEK 2321.13 1848.941 
EMSGSTSELLIaEN K a=Lys(EQTGG) 16 2438_4a 2438_4a Lys A 9 60 EMSGSTSELLIKENK 2138.03 1665.836 
GGSLPaVEA K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys A 10 60 GGSLPKVEAK 1457.76 985.5677 
GVaEEV K a=Lys(EQTGG) 8 2438_4a 2438_4a Lys A 11 60 GVKEEVK 1260.64 788.4512 
IaTEPLDFNDY K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys A 12 60 IKTEPLDFNDYK 1954.94 1482.748 
IaVEPASE K a=Lys(EQTGG) 10 2438_4a 2438_4a Lys B 1 60 IKVEPASEK 1472.76 1000.567 
IMTPSVaVE K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys B 2 60 IMTPSVKVEK 1603.84 1131.644 
aGFSEGLWEIENNPTV K a=Lys(EQTGG) 18 2438_4a 2438_4a Lys B 3 60 KGFSEGLWEIENNPTVK 2420.17 1947.981 
aPDP K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys B 4 60 KPDPK 1056.53 584.3402 
aYLI K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys B 5 60 KYLIK 1136.63 664.4392 
LaIEPSSNWDMTGYGSHS K a=Lys(EQTGG) 20 2438_4a 2438_4a Lys B 6 60 LKIEPSSNWDMTGYGSHSK 2609.19 2137.002 
LaSVA K a=Lys(EQTGG) 7 2438_4a 2438_4a Lys B 7 60 LKSVAK 1117.62 645.4294 
LaTEPEEVSIEDSAQSDL K a=Lys(EQTGG) 20 2438_4a 2438_4a Lys B 8 60 LKTEPEEVSIEDSAQSDLK 2590.24 2118.045 
LLVHMGLLaSED K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys B 9 60 LLVHMGLLKSEDK 1955.03 1482.835 
LQTMaEELDFQ K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys B 10 60 LQTMKEELDFQK 1981.95 1509.762 
LVDIa K a=Lys(EQTGG) 7 2438_4a 2438_4a Lys B 11 60 LVDIKK 1187.66 715.4713 
MALa K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys B 12 60 MALKK 1062.56 590.3694 
MAVaEE K a=Lys(EQTGG) 8 2438_4a 2438_4a Lys C 1 60 MAVKEEK 1306.63 834.439 
NEGPLNVVaTE K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys C 2 60 NEGPLNVVKTEK 1799.91 1327.722 
NGSVa K a=Lys(EQTGG) 7 2438_4a 2438_4a Lys C 3 60 NGSVKK 1104.56 632.3726 
NSDIEQSSDSaV K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys C 4 60 NSDIEQSSDSKVK 1908.88 1436.686 
QFNaLTED K a=Lys(EQTGG) 10 2438_4a 2438_4a Lys C 5 60 QFNKLTEDK 1594.77 1122.579 
QQLQQAEEALVAaQEVID K a=Lys(EQTGG) 20 2438_4a 2438_4a Lys C 6 60 QQLQQAEEALVAKQEVIDK 2640.35 2168.156 
SAEEVEEIaAE K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys C 7 60 SAEEVEEIKAEK 1833.87 1361.68 
SDQDHSMDEMTAVVaIE K a=Lys(EQTGG) 19 2438_4a 2438_4a Lys C 8 60 SDQDHSMDEMTAVVKIEK 2535.13 2062.942 
SaPIPIMPASPQ K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys C 9 60 SKPIPIMPASPQK 1865.98 1393.787 
SMSVEaIDISPVLLQ K a=Lys(EQTGG) 17 2438_4a 2438_4a Lys C 10 60 SMSVEKIDISPVLLQK 2259.19 1786.998 
STIaTDLDDDITAL K a=Lys(EQTGG) 16 2438_4a 2438_4a Lys C 11 60 STIKTDLDDDITALK 2121.06 1648.864 
TFNSELYSLNDYaPPIS K a=Lys(EQTGG) 19 2438_4a 2438_4a Lys C 12 60 TFNSELYSLNDYKPPISK 2588.25 2116.06 
TFSESLaSE K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys D 1 60 TFSESLKSEK 1627.78 1155.589 
TaAEEPSDLIGPEAP K a=Lys(EQTGG) 17 2438_4a 2438_4a Lys D 2 60 TKAEEPSDLIGPEAPK 2154.06 1681.864 
TaPDPEVEEQE K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys D 3 60 TKPDPEVEEQEK 1900.88 1428.685 
TPaEAIEGTYID K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys D 4 60 TPKEAIEGTYIDK 1936.95 1464.758 
TVFDNFFIa K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys D 5 60 TVFDNFFIKK 1730.87 1258.683 
TVTITaEDESTE K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys D 6 60 TVTITKEDESTEK 1952.93 1480.738 
VIaMESEEG K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys D 7 60 VIKMESEEGK 1621.77 1149.582 
VaTEDE K a=Lys(EQTGG) 8 2438_4a 2438_4a Lys D 8 60 VKTEDEK 1320.63 848.436 
VaVEEEEEE K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys D 9 60 VKVEEEEEEK 1719.79 1247.6 
VaVE K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys D 10 60 VKVEK 1074.58 602.3872 
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VaYT K a=Lys(EQTGG) 6 2438_4a 2438_4a Lys D 11 60 VKYTK 1110.58 638.3872 
VLDLELaGDIE K a=Lys(EQTGG) 13 2438_4a 2438_4a Lys D 12 60 VLDLELKGDIEK 1843.96 1371.773 
VLLGETGaE K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys E 1 60 VLLGETGKEK 1545.81 1073.62 
VNLDSEQAVaEE K a=Lys(EQTGG) 14 2438_4a 2438_4a Lys E 2 60 VNLDSEQAVKEEK 1960.95 1488.754 
VTTHPLAaD K a=Lys(EQTGG) 11 2438_4a 2438_4a Lys E 3 60 VTTHPLAKDK 1581.82 1109.631 
AAPGAEFAPNa R a=Lys(EQTGG) 13 2438_4b 2438_4b Arg A 1 52 AAPGAEFAPNKR 1700.84 1228.643 
ADSVGaLVTV R a=Lys(EQTGG) 12 2438_4b 2438_4b Arg A 2 52 ADSVGKLVTVR 1616.86 1144.668 
AEAMNIaIEPEETTEA R a=Lys(EQTGG) 18 2438_4b 2438_4b Arg A 3 52 AEAMNIKIEPEETTEAR 2404.13 1931.938 
AaGP R a=Lys(EQTGG) 6 2438_4b 2438_4b Arg A 4 52 AKGPR 1000.52 528.3253 
AQADIYaADFQAE R a=Lys(EQTGG) 15 2438_4b 2438_4b Arg A 5 52 AQADIYKADFQAER 2097.98 1625.792 
CPNEGCLHaMEL R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg A 6 52 CPNEGCLHKMELR 2001.89 1529.702 
DGDVVLPAGVVVaQE R a=Lys(EQTGG) 17 2438_4b 2438_4b Arg A 7 52 DGDVVLPAGVVVKQER 2153.12 1680.928 
DIaQEGETAICSEMTAD R a=Lys(EQTGG) 19 2438_4b 2438_4b Arg A 8 52 DIKQEGETAICSEMTADR 2469.09 1996.895 
EDEGFIaEEEKPLP R a=Lys(EQTGG) 16 2438_4b 2438_4b Arg A 9 52 EDEGFIKEEEKPLPR 2288.10 1815.912 
GCGVVaFESPEVAE R a=Lys(EQTGG) 16 2438_4b 2438_4b Arg A 10 52 GCGVVKFESPEVAER 2078.98 1606.789 
GSTSFLETLaTE R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg A 11 52 GSTSFLETLKTER 1940.96 1468.764 
GTGYIaTELISVSEVHPS R a=Lys(EQTGG) 20 2438_4b 2438_4b Arg A 12 52 GTGYIKTELISVSEVHPSR 2545.29 2073.098 
HIDALEDaIDEEV R a=Lys(EQTGG) 15 2438_4b 2438_4b Arg B 1 52 HIDALEDKIDEEVR 2154.03 1681.839 
HLaHL R a=Lys(EQTGG) 7 2438_4b 2438_4b Arg B 2 52 HLKHLR 1275.69 803.4999 
IAQYa R a=Lys(EQTGG) 7 2438_4b 2438_4b Arg B 3 52 IAQYKR 1250.65 778.457 
IFDEEPANGVaIE R a=Lys(EQTGG) 15 2438_4b 2438_4b Arg B 4 52 IFDEEPANGVKIER 2089.02 1616.828 
IFVGGIaEDTEEHHL R a=Lys(EQTGG) 17 2438_4b 2438_4b Arg B 5 52 IFVGGIKEDTEEHHLR 2352.16 1879.966 
IaADPDGPEAQAEACSGE R a=Lys(EQTGG) 20 2438_4b 2438_4b Arg B 6 52 IKADPDGPEAQAEACSGER 2416.07 1943.876 
IaEEEEGAEASA R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg B 7 52 IKEEEEGAEASAR 1890.87 1418.676 
IaVE R a=Lys(EQTGG) 6 2438_4b 2438_4b Arg B 8 52 IKVER 1116.60 644.409 
INEILSNALa R a=Lys(EQTGG) 12 2438_4b 2438_4b Arg B 9 52 INEILSNALKR 1742.94 1270.748 
aANLL R a=Lys(EQTGG) 7 2438_4b 2438_4b Arg B 10 52 KANLLR 1186.65 714.4621 
aYYYYE R a=Lys(EQTGG) 8 2438_4b 2438_4b Arg B 11 52 KYYYYER 1556.70 1084.51 
LLLGSPSSLSPFSa R a=Lys(EQTGG) 16 2438_4b 2438_4b Arg B 12 52 LLLGSPSSLSPFSKR 2061.10 1588.906 
LLQaPL R a=Lys(EQTGG) 8 2438_4b 2438_4b Arg C 1 52 LLQKPLR 1339.77 867.5774 
LTDNIaYEDCED R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg C 2 52 LTDNIKYEDCEDR 2085.90 1613.711 
LTEDaADVQSIIGLQ R a=Lys(EQTGG) 17 2438_4b 2438_4b Arg C 3 52 LTEDKADVQSIIGLQR 2258.16 1785.971 
MNaSEDDESGAGELT R a=Lys(EQTGG) 17 2438_4b 2438_4b Arg C 4 52 MNKSEDDESGAGELTR 2210.95 1738.755 
NaEIMY R a=Lys(EQTGG) 8 2438_4b 2438_4b Arg C 5 52 NKEIMYR 1425.68 953.4873 
QATSISSETaNTL R a=Lys(EQTGG) 15 2438_4b 2438_4b Arg C 6 52 QATSISSETKNTLR 2007.99 1535.802 
QQEGFaGTFPDA R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg C 7 52 QQEGFKGTFPDAR 1952.91 1480.718 
QSLaQGS R a=Lys(EQTGG) 9 2438_4b 2438_4b Arg C 8 52 QSLKQGSR 1375.69 903.5007 
SSIaQEPIE R a=Lys(EQTGG) 11 2438_4b 2438_4b Arg C 9 52 SSIKQEPIER 1658.83 1186.643 
SSVaVEAEAS R a=Lys(EQTGG) 12 2438_4b 2438_4b Arg C 10 52 SSVKVEAEASR 1634.80 1162.606 
TDLDDDITALaQ R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg C 11 52 TDLDDDITALKQR 1975.96 1503.765 
TLAEIAaVELDNMPL R a=Lys(EQTGG) 17 2438_4b 2438_4b Arg C 12 52 TLAEIAKVELDNMPLR 2285.18 1812.989 
TSDADIaSSETGAF R a=Lys(EQTGG) 16 2438_4b 2438_4b Arg D 1 52 TSDADIKSSETGAFR 2056.94 1584.75 
VENGQEPVIaLEN R a=Lys(EQTGG) 15 2438_4b 2438_4b Arg D 2 52 VENGQEPVIKLENR 2097.06 1624.865 
VGVaSAP R a=Lys(EQTGG) 9 2438_4b 2438_4b Arg D 3 52 VGVKSAPR 1285.69 813.4941 
VaEDPDGEHA R a=Lys(EQTGG) 12 2438_4b 2438_4b Arg D 4 52 VKEDPDGEHAR 1724.78 1252.592 
VaEEPPSPPQSP R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg D 5 52 VKEEPPSPPQSPR 1919.95 1447.754 
VaLDSV R a=Lys(EQTGG) 8 2438_4b 2438_4b Arg D 6 52 VKLDSVR 1288.69 816.4938 
VVHIDSGIVaQE R a=Lys(EQTGG) 14 2438_4b 2438_4b Arg D 7 52 VVHIDSGIVKQER 1952.02 1479.828 
WMaHEPGLGSYGDELG R a=Lys(EQTGG) 18 2438_4b 2438_4b Arg D 8 52 WMKHEPGLGSYGDELGR 2404.10 1931.907 
YaWEYTYYS R a=Lys(EQTGG) 11 2438_4b 2438_4b Arg D 9 52 YKWEYTYYSR 1930.86 1458.669 
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Table 14: List of the 96 SUMO 3 peptides synthetic par PJG Berlin 
Sequences synthesized 
C-
terminus 
Comments 
Length w/o 
C-term 
Synthesis-# Plate-# Row Column 
Amount/Well 
[nmol] 
sequence 
Peptide 
SUMO 
Peptide 
            
ADILEDrDG K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys A 1 60 ADILEDKDGK 1560.75 1103.5579 
AFITNIPFDVrWQSL K r=Lys(NQTGG) 17 2438_5a 2438_5a Lys A 2 60 AFITNIPFDVKWQSLK 2364.23 1907.0425 
AYQrQPTIFQN K r=Lys(NQTGG) 13 2438_5a 2438_5a Lys A 3 60 AYQKQPTIFQNK 1922.97 1465.7798 
DGrYSQVLANGLDN K r=Lys(NQTGG) 16 2438_5a 2438_5a Lys A 4 60 DGKYSQVLANGLDNK 2079.01 1621.818 
EGVrTENDHINL K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys A 5 60 EGVKTENDHINLK 1953.96 1496.7703 
ELSEVrNVLE K r=Lys(NQTGG) 12 2438_5a 2438_5a Lys A 6 60 ELSEVKNVLEK 1744.91 1287.7155 
EMSGSTSELLIrEN K r=Lys(NQTGG) 16 2438_5a 2438_5a Lys A 7 60 EMSGSTSELLIKENK 2123.03 1665.8364 
FrQEPEDELPEAPP K r=Lys(NQTGG) 16 2438_5a 2438_5a Lys A 8 60 FKQEPEDELPEAPPK 2211.06 1753.8643 
GrYKEETIE K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys A 9 60 GKYKEETIEK 1681.84 1224.647 
HTPLSrLM K r=Lys(NQTGG) 10 2438_5a 2438_5a Lys A 10 60 HTPLSKLMK 1511.80 1054.6078 
IESESrGIKGG K r=Lys(NQTGG) 13 2438_5a 2438_5a Lys A 11 60 IESESKGIKGGK 1689.88 1232.6845 
IGAIrQESEEPPT K r=Lys(NQTGG) 15 2438_5a 2438_5a Lys A 12 60 IGAIKQESEEPPTK 1984.00 1526.8061 
IIVDELrQEVISTSS K r=Lys(NQTGG) 17 2438_5a 2438_5a Lys B 1 60 IIVDELKQEVISTSSK 2246.19 1788.9953 
IrDEPDNAQEYSHGQQQ K r=Lys(NQTGG) 19 2438_5a 2438_5a Lys B 2 60 IKDEPDNAQEYSHGQQQK 2572.17 2114.9738 
ITAFrME K r=Lys(NQTGG) 9 2438_5a 2438_5a Lys B 3 60 ITAFKMEK 1424.72 967.5281 
ITPEEArY K r=Lys(NQTGG) 10 2438_5a 2438_5a Lys B 4 60 ITPEEAKYK 1535.77 1078.5779 
LrVIGQDSSEIHF K r=Lys(NQTGG) 15 2438_5a 2438_5a Lys B 5 60 LKVIGQDSSEIHFK 2058.06 1600.8693 
LLVHMGLLrSED K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys B 6 60 LLVHMGLLKSEDK 1940.03 1482.8349 
NDQNNSDTrISETETL K r=Lys(NQTGG) 18 2438_5a 2438_5a Lys B 7 60 NDQNNSDTKISETETLK 2394.10 1936.9094 
NISIrQEP K r=Lys(NQTGG) 10 2438_5a 2438_5a Lys B 8 60 NISIKQEPK 1513.80 1056.6048 
NLrQNLSELEQLNENL K r=Lys(NQTGG) 18 2438_5a 2438_5a Lys B 9 60 NLKQNLSELEQLNENLK 2484.27 2027.0768 
NQTILr K r=Lys(NQTGG) 8 2438_5a 2438_5a Lys B 10 60 NQTILKK 1301.72 844.5251 
QFNrLTED K r=Lys(NQTGG) 10 2438_5a 2438_5a Lys B 11 60 QFNKLTEDK 1579.77 1122.579 
QSLVMLQGNrLDITTE K r=Lys(NQTGG) 18 2438_5a 2438_5a Lys B 12 60 QSLVMLQGNKLDITTEK 2375.22 1918.0314 
RPrVEYSEEEL K r=Lys(NQTGG) 13 2438_5a 2438_5a Lys C 1 60 RPKVEYSEEELK 1963.97 1506.7798 
SAEEVEEIrAE K r=Lys(NQTGG) 13 2438_5a 2438_5a Lys C 2 60 SAEEVEEIKAEK 1818.87 1361.6795 
STIrTDLDDDITAL K r=Lys(NQTGG) 16 2438_5a 2438_5a Lys C 3 60 STIKTDLDDDITALK 2106.06 1648.864 
TFSESLrSE K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys C 4 60 TFSESLKSEK 1612.78 1155.5892 
TrAEEPSDLIGPEAP K r=Lys(NQTGG) 17 2438_5a 2438_5a Lys C 5 60 TKAEEPSDLIGPEAPK 2139.06 1681.8643 
TrPDPEVEEQE K r=Lys(NQTGG) 13 2438_5a 2438_5a Lys C 6 60 TKPDPEVEEQEK 1885.88 1428.6853 
TPrEAIEGTYID K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys C 7 60 TPKEAIEGTYIDK 1921.95 1464.7581 
TVFDNFFIr K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys C 8 60 TVFDNFFIKK 1715.88 1258.683 
TVTITrEDESTE K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys C 9 60 TVTITKEDESTEK 1937.93 1480.7377 
VAGGArE K r=Lys(NQTGG) 9 2438_5a 2438_5a Lys C 10 60 VAGGAKEK 1216.63 759.4359 
VGEPEVrEE K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys C 11 60 VGEPEVKEEK 1600.78 1143.5892 
VrEEHLDVASPD K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys C 12 60 VKEEHLDVASPDK 1923.94 1466.7485 
VrFEQNGSS K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys D 1 60 VKFEQNGSSK 1580.77 1123.5742 
VLLGETGrE K r=Lys(NQTGG) 11 2438_5a 2438_5a Lys D 2 60 VLLGETGKEK 1530.81 1073.6201 
VNLDSEQAVrEE K r=Lys(NQTGG) 14 2438_5a 2438_5a Lys D 3 60 VNLDSEQAVKEEK 1945.95 1488.754 
YrEETIE K r=Lys(NQTGG) 9 2438_5a 2438_5a Lys D 4 60 YKEETIEK 1496.72 1039.5306 
ADSLLAVVr R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg A 1 52 ADSLLAVVKR 1528.84 1071.6521 
AEAMNIrIEPEETTEA R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg A 2 52 AEAMNIKIEPEETTEAR 2389.13 1931.9379 
APGQHGGFVVTVrQE R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg A 3 52 APGQHGGFVVTVKQER 2167.10 1709.9082 
APTASQERPrEELGAG R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg A 4 52 APTASQERPKEELGAGR 2254.12 1796.925 
ATGDETGArVE R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg A 5 52 ATGDETGAKVER 1690.80 1233.607 
ATMHLrQEVTP R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg A 6 52 ATMHLKQEVTPR 1867.94 1410.7522 
EEDAErAVIDLNN R r=Lys(NQTGG) 15 2438_5b 2438_5b Arg A 7 52 EEDAEKAVIDLNNR 2072.98 1615.7922 
EIAQDFrTDL R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg A 8 52 EIAQDFKTDLR 1792.88 1335.6903 
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ErLEMEMEAA R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg A 9 52 EKLEMEMEAAR 1793.82 1336.6235 
ErLTADPDSEIATTSL R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg A 10 52 EKLTADPDSEIATTSLR 2304.13 1846.9393 
FQIIrQEPMELESYT R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg A 11 52 FQIIKQEPMELESYTR 2469.21 2012.0157 
GPTLGASAPVTVr R r=Lys(NQTGG) 15 2438_5b 2438_5b Arg A 12 52 GPTLGASAPVTVKR 1810.98 1353.7849 
GTAGLLEQWLr R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg B 1 52 GTAGLLEQWLKR 1828.97 1371.7743 
GVPDArI R r=Lys(NQTGG) 9 2438_5b 2438_5b Arg B 2 52 GVPDAKIR 1312.70 855.5047 
GYFEYIEENrYS R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg B 3 52 GYFEYIEENKYSR 2154.97 1697.7806 
HHSLALTSFr R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg B 4 52 HHSLALTSFKR 1753.91 1296.7171 
IEEIrDFLLTA R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg B 5 52 IEEIKDFLLTAR 1905.01 1447.8155 
IFDEEPANGVrIE R r=Lys(NQTGG) 15 2438_5b 2438_5b Arg B 6 52 IFDEEPANGVKIER 2074.02 1616.8279 
IrEDDAP R r=Lys(NQTGG) 9 2438_5b 2438_5b Arg B 7 52 IKEDDAPR 1400.68 943.4843 
IrIEPGIEPQ R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg B 8 52 IKIEPGIEPQR 1736.93 1279.7369 
IrSGEVAEGEA R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg B 9 52 IKSGEVAEGEAR 1702.84 1245.6434 
IrVEPASEKDPESL R r=Lys(NQTGG) 16 2438_5b 2438_5b Arg B 10 52 IKVEPASEKDPESLR 2155.10 1697.9068 
INEILSNALr R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg B 11 52 INEILSNALKR 1727.94 1270.7478 
rAEAGAGSATEFQF R r=Lys(NQTGG) 16 2438_5b 2438_5b Arg B 12 52 KAEAGAGSATEFQFR 2026.96 1569.7656 
rDDEVQVV R r=Lys(NQTGG) 10 2438_5b 2438_5b Arg C 1 52 KDDEVQVVR 1544.77 1087.5742 
rEETVEDEIDV R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg C 2 52 KEETVEDEIDVR 1918.90 1461.7067 
rNAALVT R r=Lys(NQTGG) 9 2438_5b 2438_5b Arg C 3 52 KNAALVTR 1329.72 872.5312 
rVEEDEAGG R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg C 4 52 KVEEDEAGGR 1546.71 1089.5171 
LrEDVLEQ R r=Lys(NQTGG) 10 2438_5b 2438_5b Arg C 5 52 LKEDVLEQR 1586.81 1129.6212 
LrTEEGEIDYSAEEGEN R r=Lys(NQTGG) 19 2438_5b 2438_5b Arg C 6 52 LKTEEGEIDYSAEEGENR 2526.12 2068.9305 
LTEDrADVQSIIGLQ R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg C 7 52 LTEDKADVQSIIGLQR 2243.16 1785.9705 
MrFNPFVTSD R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg C 8 52 MKFNPFVTSDR 1798.85 1341.662 
MNrSEDDESGAGELT R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg C 9 52 MNKSEDDESGAGELTR 2195.95 1738.7548 
NLLHDNELSDLrEDKP R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg C 10 52 NLLHDNELSDLKEDKPR 2493.23 2036.0407 
NLYrNVILENY R r=Lys(NQTGG) 13 2438_5b 2438_5b Arg C 11 52 NLYKNVILENYR 1996.02 1538.8326 
NSIDASEErPVM R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg C 12 52 NSIDASEEKPVMR 1932.91 1475.7159 
QLATrAA R r=Lys(NQTGG) 9 2438_5b 2438_5b Arg D 1 52 QLATKAAR 1315.71 858.5156 
QQEGFrGTFPDA R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg D 2 52 QQEGFKGTFPDAR 1937.91 1480.7179 
SGLrHELVT R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg D 3 52 SGLKHELVTR 1596.85 1139.6531 
SSVrVEAEAS R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg D 4 52 SSVKVEAEASR 1619.80 1162.6062 
STPrEETVNDPEEAGH R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg D 5 52 STPKEETVNDPEEAGHR 2353.07 1895.873 
STYADEELVIrAEGLA R r=Lys(NQTGG) 18 2438_5b 2438_5b Arg D 6 52 STYADEELVIKAEGLAR 2322.16 1864.9651 
SVHSQDPSGDSrLY R r=Lys(NQTGG) 16 2438_5b 2438_5b Arg D 7 52 SVHSQDPSGDSKLYR 2133.00 1675.8034 
TDLDDDITALrQ R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg D 8 52 TDLDDDITALKQR 1960.96 1503.7649 
TLAEIArVELDNMPL R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg D 9 52 TLAEIAKVELDNMPLR 2270.18 1812.9888 
TLSDYNIQrESTLHLVL R r=Lys(NQTGG) 19 2438_5b 2438_5b Arg D 10 52 TLSDYNIQKESTLHLVLR 2587.35 2130.1553 
TSDADIrSSETGAF R r=Lys(NQTGG) 16 2438_5b 2438_5b Arg D 11 52 TSDADIKSSETGAFR 2041.94 1584.75 
VrEDPDGEHA R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg D 12 52 VKEDPDGEHAR 1709.78 1252.5917 
VrLDSV R r=Lys(NQTGG) 8 2438_5b 2438_5b Arg E 1 52 VKLDSVR 1273.69 816.4938 
VQIrQETIES R r=Lys(NQTGG) 12 2438_5b 2438_5b Arg E 2 52 VQIKQETIESR 1787.92 1330.7325 
VSISEGDDrIEY R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg E 3 52 VSISEGDDKIEYR 1967.93 1510.7384 
VVHIDSGIVrQE R r=Lys(NQTGG) 14 2438_5b 2438_5b Arg E 4 52 VVHIDSGIVKQER 1937.02 1479.8278 
WTVVrTEEG R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg E 5 52 WTVVKTEEGR 1661.82 1204.6321 
YEEALSQLEESVrEE R r=Lys(NQTGG) 17 2438_5b 2438_5b Arg E 6 52 YEEALSQLEESVKEER 2396.12 1938.9291 
YrWEYTYYS R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg E 7 52 YKWEYTYYSR 1915.86 1458.6688 
YQrSTELLI R r=Lys(NQTGG) 11 2438_5b 2438_5b Arg E 8 52 YQKSTELLIR 1708.64 1251.4518 
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6.5. CAPILLARY COLUMN PACKING  
 
Introduction 
This protocol uses a nitrogen tank and an empty HPLC column as a reservoir. 
 
Protocol 
1-Preparation of the precolumn 
a- Cut a 3-cm piece of TFE tubing (0.3 mm ID × 1.58 mm OD Sigma cat#58702). 
b- Cut a 5-cm piece of 50 um ID (50 um ID 375 um OD Molex TSP050375).  
c- Place a piece of SDB membrane at the end of the piece of teflon tubing and push it 
inside with the piece of capillary until it is at 2-cm of the TFE tubing inlet. 
d- Put a piece of 150 um ID capillary (150 um ID 375 um OD Molex TSP150375) at the 
other end of the Teflon tubing. Just slightly push it inside the Teflon tubing (3mm). 
e- Connect the  other end of the 150 um id capillary to the empty HPLC column with a 
ferrule. 
f- Add stationary phase (tip of a spatula) to 1 ml of ACN in an eppendorf tube. Mix 
thoroughly. 
g- Put the slurry packing in the empty HPLC column and connect it to the N2 tank. 
h- Increase the pressure to 50-100 psi and pack the TFE tubing over 5mm. Close the N2 
tank and let the setup go back to ambient pressure. 
i- Take the HPLC column off the tank. Remove the TFE tubing from the piece of 150 
um-id capillary.  
j- Place a piece of SDB membrane at the free end of the piece of teflon tubing and 
push it inside with the piece of capillary until it reaches the stationary phase. 
k- The precolumn is ready to use. 
 
2-Column packing 
a- Cut a 2-cm piece of TFE tubing (0.3 mm ID × 1.58 mm OD Sigma cat#58702). 
b- Cut a 5-cm piece of 50 um ID (50 um ID 375 um OD Molex TSP050375).  
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c- Place a piece of SDB membrane at the end of the piece of teflon tubing and push it 
inside with the piece of capillary until it is at 1-cm of the TFE tubing inlet. 
d- Put a piece of 17-cm of 150 um ID capillary (150 um ID 375 um OD Molex 
TSP150375) at the other end of the Teflon tubing. Just push it inside the Teflon 
tubing until it reaches the membrane. 
e- Connect the other end of the 150-um id capillary to the HPLC column. 
f- Put the remaining slurry packing used for the precolumn in the empty HPLC column 
and connect it to the N2 tank. 
g- Increase the pressure to 100 psi. The column will start to pack. Raise the pressure 
slowly during the column packing (until 1000 psi) until 15 cm are packed. 
l-  Close the N2 tank and let the setup go back to ambient pressure. 
m- Take the column off the HPLC. You can connect the column with a piece of Teflon 
tubing with a piece of membrane in it to any piece of capillary connected to a 
load/inject valve 
 
Hints and pitfalls 
1- If you raise the pressure too fast, the column will not pack correctly.  
2- DO NOT CONNECT the column inlet directly on the valve without any frit since some 
stationary phase might get into the valve when the valve switches. 
3- You can help packing with a dremmel by ‘dremmeling’ the outlet of the HPLC column.
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6.6. PROMIX 08/07/2014 
a- 50 mM Ammoniumbicarbonat ex BioBasic VWR #CA99501 (395.5mg/100 ml 
Millipore water store at 4°C) 
b- Weight in a tube 1mg protein and dissolve in 1ml 50mM Ammoniumbicarbonat 
mg/ml   
Intensity 100ng 
digested 
1.03  
Alcohol Dehydrogenase from Saccharomyces 
cerevisiae 
Sigma A7011, 
LOT# 041M7354V 4.2E 8 
1.30 Bovine Serum Albumin 
BioShop ALB00150, 
LOT# 3927998 
7.2 E8 
1.18 Carbonic Anhydrase from bovine erythrocytes 
Sigma C3934, 
LOT# 081M1626V 
5.2 E7 
0.99 Cytochrome c from Saccharomyces cerevisiae 
Sigma C2436, 
LOT# 037K7008V 
1.0 E9 
1.02 Enolase from Saccharomyces cerevisiae 
Sigma E6126, 
LOT| 097K7690V 
3.6 E8 
1.15 Hemoglobin human 
Sigma H7379,  
LOT# SLBC0633V 1.3 E8 
1.24 Phosphorylase b from rabbit muscle 
Sigma P6635, 
LOT# 110M7675V 
7.4 E8 
1.06 Transferrin human 
Sigma T3309, 
LOT| 0L194488 
3.7 E8 
c- Add 30 ul TCEP sol ex Thermo 77720 (LOT # 0L194488). Incubate for 30min at 37°C, 
450 rmp 
d- Add 100ul of 5mg/ml Chloroacetamide solution [6.87mg 2-Chloroacetamide ex 
Sigma C0267/1.4 ml 50mM Ammoniumbicarbonat]. Incubate for 30min at 37°C, 450 
rmp 
e- Add 20ug Trypsin (modified Trypsin ex Promega V511A LOT # 97191) dissolved in 
100 ul 50mM Ammoniumbicarbonat. Incubate over night at 37°C, 450 rmp 
f- For 100ng peptide: 100 times dilution of the peptide solution with 0.2% Formic acid:  
g- 5ul peptide solution + 495ul 0.2% FA (pH ~ 3). 1000ng/ul  10ng/ul; Injection 
Volume: 10 ul 
Digested peptide solution 
175 ul  Alcohol Dehydrogenase from Saccharomyces cerevisiae 
In a 50ml Volumen flask 
and fill up with 0.2% FA 
to the mark. 
105 ul Bovine Serum Albumin 
850 ul Carbonic Anhydrase from bovine erythrocytes 
75 ul Cytochrome c from Saccharomyces cerevisiae 
210 ul Enolase from Saccharomyces cerevisiae 
575 ul Hemoglobin human 
95 ul Phosphorylase b from rabbit muscle 
205 ul Transferrin human 
 
500 ul aliquots, dryed with the speed vac. 
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6.7. GROUP PROFESSOR DR.PIERRE THIBAULT 
 
Figure 46: The photo shows (from right): Anja Roderbrock, Prof. Dr. Pierre Thibault, Sibylle Pfammatter, Dr. Francis McManus, Irene Campoy Mocayo, Nebiyu Abshiru, 
Christine Desroches, Peter Kubiniok, Christelle Pomies, Dr. Eric Bonneil, Dr. Christina Bell, Dr. Evgeny Kanshin, Olivier Caron-Lizotte and Frederic Lamoliatte. 
 
